HPV vaccine (English Wikipedia)

"Human Papillomavirus (HPV) Vaccines: Q & A". Fact Sheets: Risk Factors and Possible Causes. National Cancer Institute (NCI). 22 October 2009. Archived from the original on 21 June 2008. Retrieved 18 July 2008.
"Human Papillomavirus (HPV) Vaccines". 25 May 2018. Archived from the original on 4 July 2014.

cancerresearchuk.org

info.cancerresearchuk.org

"Gay men seeking HPV vaccine". Cancer Research UK. 23 February 2007. Archived from the original on 24 March 2010. Retrieved 30 October 2009.

cancerscreening.nhs.uk

"NHS Cervical Screening Program". Archived from the original on 14 September 2008. Retrieved 26 June 2008.

caracol.com.co

"Vacuna contra el Papiloma Humano será gratuita". Caracol Radio. No. Actualidad. Prisa Radio. 3 May 2013. Retrieved 29 July 2015.^{[permanent dead link]}

caribbeanmedicalnews.com

"HPV vaccine for first form students in Barbados while Trinidad suspends the same in schools". Caribbean Medical News. 1 December 2013. Archived from the original on 27 October 2021. Retrieved 27 October 2021.

cbsnews.com

Attkisson S (19 August 2009). "Gardasil Researcher Speaks Out". CBS News. Archived from the original on 3 March 2022. Retrieved 3 March 2022.

cdc.gov

"What's New with VISs". Centers for Disease Control and Prevention (CDC). 5 April 2019. Archived from the original on 15 October 2019. Retrieved 14 October 2019.
"HPV Vaccination: What Everyone Should Know". CDC. 6 May 2022. Retrieved 22 February 2023.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (August 2019). "Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (32): 698–702. doi:10.15585/mmwr.mm6832a3. PMC 6818701. PMID 31415491. Archived (PDF) from the original on 13 October 2019. Retrieved 15 October 2019.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (March 2007). "Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 56 (RR-2): 1–24. PMID 17380109. Archived (PDF) from the original on 24 September 2015.
"HPV Vaccines". Centers for Disease Control and Prevention (CDC). 15 October 2010. Archived from the original on 4 October 2015. Retrieved 27 February 2011.
"Meeting of the Advisory Committee on Immunization Practices (ACIP)" (PDF). Centers for Disease Control and Prevention (CDC). 14 October 2016. Archived (PDF) from the original on 21 October 2016. Retrieved 21 October 2016.
Centers for Disease Control and Prevention (CDC) (May 2010). "FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Morbidity and Mortality Weekly Report. 59 (20): 630–632. PMID 20508594. Archived (PDF) from the original on 24 September 2015.
"Vaccine Information Statement". Centers for Disease Control and Prevention (CDC). Archived from the original on 21 November 2015. Retrieved 20 November 2015.
"Reports of Health Concerns Following HPV Vaccination". Centers for Disease Control and Prevention (CDC). 5 November 2009. Archived from the original on 17 September 2013. Retrieved 8 September 2013.
"Information from FDA and CDC on Gardasil and its Safety". Centers for Disease Control and Prevention (CDC). 22 July 2008. Archived from the original on 2 September 2013. Retrieved 8 September 2013.
"HPV Vaccine Information for Clinicians – Fact Sheet". CDC. 11 January 2019. Archived from the original on 1 May 2012.
"Who Should NOT Get Vaccinated with these Vaccines?". Centers for Disease Control and Prevention (CDC). 10 June 2010. Archived from the original on 11 May 2011. Retrieved 27 February 2011.
"The Genital HPV Infection Fact Sheet". Centers for Disease Control and Prevention (CDC). 24 November 2009. Archived from the original on 28 June 2013. Retrieved 13 February 2010.
"New technologies for cervical cancer prevention: from scientific evidence to program planning". Pan American Health Organization. Archived from the original on 9 May 2012. Retrieved 18 April 2012.
"Progress Toward Implementation of Human Papillomavirus Vaccination—the Americas, 2006–2010". Center for Disease and Control Prevention. Archived from the original on 9 May 2012. Retrieved 18 April 2012.
"HPV Vaccine Information For Young Women". Centers for Disease Control and Prevention (CDC). Archived from the original on 28 June 2009. Retrieved 14 June 2009.
"Vaccines for Children Program (VFC)". Centers for Disease Control and Prevention. Archived from the original on 28 September 2013. Retrieved 10 August 2013.
"Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans — United States, 2013". Center of Disease Control and Prevention. 30 October 2015. Archived from the original on 18 October 2020. Retrieved 10 September 2020.
"About VFC". Centers for Disease Control and Prevention (CDC). 25 May 2018. Archived from the original on 7 November 2018. Retrieved 7 November 2018.

chp.gov.hk

"Centre for Health Protection, Department of Health - About human papillomavirus (HPV) vaccination". www.chp.gov.hk. Archived from the original on 8 March 2021. Retrieved 15 August 2020.

clinicaltrials.gov

"REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)". clinicaltrials.gov. The National Library of Medicine. Archived from the original on 2 November 2017. Retrieved 2 November 2017.

columbiatribune.com

"A question of protection". Archived from the original on 15 October 2007. Retrieved 16 October 2019.

dddmag.com

"More US Girls Now Getting Cervical Cancer Vaccine". Discovery and Development. Associated Press. 25 July 2014. Archived from the original on 26 July 2014.

dh.gov.uk

immunisation.dh.gov.uk

"HPV vaccination programme switching to Gardasil from September 2012". immunisation.dh.gov.uk. Department of Health. 28 November 2011. Archived from the original on 4 January 2013. Retrieved 3 January 2019.

dn.pt

"Vacinas: Meningite B e HPV para rapazes passam a ser gratuitas em 2020 - DN". www.dn.pt (in Portuguese). 27 December 2019. Archived from the original on 30 January 2020. Retrieved 30 January 2020.

doi.org

Kash N, Lee MA, Kollipara R, Downing C, Guidry J, Tyring SK (April 2015). "Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus". Journal of Clinical Medicine. 4 (4): 614–633. doi:10.3390/jcm4040614. PMC 4470159. PMID 26239350. S2CID 14149551.
De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (April 2009). "Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis". International Journal of Cancer. 124 (7): 1626–1636. doi:10.1002/ijc.24116. PMID 19115209. S2CID 24197494.
Takes RP, Wierzbicka M, D'Souza G, Jackowska J, Silver CE, Rodrigo JP, et al. (December 2015). "HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?". Oral Oncology. 51 (12): 1057–1060. doi:10.1016/j.oraloncology.2015.10.011. PMID 26520047. S2CID 23356354.
Thaxton L, Waxman AG (May 2015). "Cervical cancer prevention: immunization and screening 2015". The Medical Clinics of North America. 99 (3): 469–477. doi:10.1016/j.mcna.2015.01.003. PMID 25841595. S2CID 2828633.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". StatPearls (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
Saville AM (April 2016). "Cervical cancer prevention in Australia: Planning for the future". Cancer Cytopathology. 124 (4): 235–240. doi:10.1002/cncy.21643. PMID 26619381.
Hotez PJ, Bottazzi ME (January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55–64. doi:10.1146/annurev-med-042420-113212. PMID 34637324. S2CID 238747462.
Fesenfeld M, Hutubessy R, Jit M (August 2013). "Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review". Vaccine. 31 (37): 3786–3804. doi:10.1016/j.vaccine.2013.06.060. PMID 23830973.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (August 2019). "Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (32): 698–702. doi:10.15585/mmwr.mm6832a3. PMC 6818701. PMID 31415491. Archived (PDF) from the original on 13 October 2019. Retrieved 15 October 2019.
Drolet M, Bénard É, Pérez N, Brisson M (August 2019). "Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis". Lancet. 394 (10197): 497–509. doi:10.1016/S0140-6736(19)30298-3. PMC 7316527. PMID 31255301.
Cox B, Sneyd MJ (2018). "HPV screening, invasive cervical cancer and screening policy in Australia". Journal of the American Society of Cytopathology. 7 (6): 292–299. doi:10.1016/j.jasc.2018.07.003. PMID 31043298. S2CID 58548623.
Lew JB, Simms KT, Smith MA, Hall M, Kang YJ, Xu XM, et al. (February 2017). "Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program". The Lancet. Public Health. 2 (2): e96–e107. doi:10.1016/S2468-2667(17)30007-5. PMID 29253402.
Arbyn M, Xu L, Simoens C, Martin-Hirsch PP (May 2018). "Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors". The Cochrane Database of Systematic Reviews. 5 (3): CD009069. doi:10.1002/14651858.CD009069.pub3. PMC 4176676. PMID 29740819. CD009069.
Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. (April 2006). "Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial". Lancet. 367 (9518): 1247–1255. doi:10.1016/S0140-6736(06)68439-0. PMID 16631880. S2CID 18685310.
De Vincenzo R, Conte C, Ricci C, Scambia G, Capelli G (3 December 2014). "Long-term efficacy and safety of human papillomavirus vaccination". International Journal of Women's Health. 6: 999–1010. doi:10.2147/IJWH.S50365. PMC 4262378. PMID 25587221.
"Committee opinion no. 467: human papillomavirus vaccination". Obstetrics and Gynecology. 116 (3): 800–803. September 2010. doi:10.1097/AOG.0b013e3181f680c8. PMID 20733476.
|Tay SK (February 2012). "Cervical cancer in the human papillomavirus vaccination era". Current Opinion in Obstetrics & Gynecology. 24 (1): 3–7. doi:10.1097/GCO.0b013e32834daed9. PMID 22123221. S2CID 23213383.
Jit M, Brisson M, Laprise JF, Choi YH (January 2015). "Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model". BMJ. 350: g7584. doi:10.1136/bmj.g7584. PMC 4285892. PMID 25567037.
Sonawane K, Nyitray AG, Nemutlu GS, Swartz MD, Chhatwal J, Deshmukh AA (December 2019). "Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women". JAMA Network Open. 2 (12): e1918571. doi:10.1001/jamanetworkopen.2019.18571. PMC 6986697. PMID 31880792.
Zou Z, Zhang L (October 2023). "The one-dose schedule opens the door to rapid scale-up of HPV vaccination". BMC Medicine. 21 (1): 387. doi:10.1186/s12916-023-03097-x. PMC 10561457. PMID 37807059.
Markowitz LE, Unger ER (May 2023). "Human Papillomavirus Vaccination". The New England Journal of Medicine. 388 (19): 1790–1798. doi:10.1056/NEJMcp2108502. PMID 37163625. S2CID 264642213.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. (February 2015). "A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women". The New England Journal of Medicine. 372 (8): 711–723. doi:10.1056/NEJMoa1405044. PMID 25693011.
Schuchat A (February 2015). "HPV "coverage"". The New England Journal of Medicine. 372 (8): 775–776. doi:10.1056/NEJMe1415742. PMC 6009818. PMID 25693018.
Chow EP, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, et al. (December 2021). "Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18". The Lancet. Infectious Diseases. 21 (12): 1747–1756. doi:10.1016/S1473-3099(21)00071-2. PMID 34339639. S2CID 236884872.
Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK (May 2015). "Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme". Sexually Transmitted Infections. 91 (3): 214–219. doi:10.1136/sextrans-2014-051813. PMID 25305210. S2CID 24549759.
Chow EP, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Garland SM, et al. (October 2021). "Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study". The Lancet. Infectious Diseases. 21 (10): 1448–1457. doi:10.1016/S1473-3099(20)30687-3. PMID 34043963. S2CID 235230838.
Chow EP, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, et al. (January 2017). "Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study". The Lancet. Infectious Diseases. 17 (1): 68–77. doi:10.1016/S1473-3099(16)30116-5. PMID 27282422.
Castle PE, Scarinci I (October 2009). "Should HPV vaccine be given to men?". BMJ. 339 (7726): b4127. doi:10.1136/bmj.b4127. PMID 19815585. S2CID 1922594.
Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al. (August 2004). "Against which human papillomavirus types shall we vaccinate and screen? The international perspective". International Journal of Cancer. 111 (2): 278–285. doi:10.1002/ijc.20244. PMID 15197783. S2CID 20679802.
Wittet S, Tsu V (June 2008). "Cervical cancer prevention and the Millennium Development Goals". Bulletin of the World Health Organization. 86 (6): 488–490. doi:10.2471/BLT.07.050450. PMC 2647477. PMID 18568279.
Moghtaderi A, Dor A (April 2021). "Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening". Medical Care Research and Review. 78 (2): 125–137. doi:10.3386/w22523. PMID 31096862.
Goss MA, Lievano F, Buchanan KM, Seminack MM, Cunningham ML, Dana A (June 2015). "Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine". Vaccine. 33 (29): 3422–3428. doi:10.1016/j.vaccine.2015.04.014. PMID 25869893.
Lowy DR, Schiller JT (May 2006). "Prophylactic human papillomavirus vaccines". The Journal of Clinical Investigation. 116 (5): 1167–1173. doi:10.1172/JCI28607. PMC 1451224. PMID 16670757.
McNeil C (April 2006). "Who invented the VLP cervical cancer vaccines?". Journal of the National Cancer Institute. 98 (7): 433. doi:10.1093/jnci/djj144. PMID 16595773.
Kim JJ, Goldie SJ (October 2009). "Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States". BMJ. 339 (7726): b3884. doi:10.1136/bmj.b3884. PMC 2759438. PMID 19815582.
Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. (September 2007). "Human papillomavirus and HPV vaccines: a review". Bulletin of the World Health Organization. 85 (9): 719–726. doi:10.2471/BLT.06.038414. PMC 2636411. PMID 18026629.
Ko JS, Goldbeck CS, Baughan EB, Klausner JD (September 2020). "Association Between Human Papillomavirus Vaccination School-Entry Requirements and Vaccination Initiation". JAMA Pediatrics. 174 (9): 861–867. doi:10.1001/jamapediatrics.2020.1852. PMC 7325070. PMID 32597928.
Thompson EL, Livingston MD, Daley EM, Saslow D, Zimet GD (August 2020). "Rhode Island Human Papillomavirus Vaccine School Entry Requirement Using Provider-Verified Report". American Journal of Preventive Medicine. 59 (2): 274–277. doi:10.1016/j.amepre.2020.02.022. hdl:1805/28509. PMID 32430223. S2CID 218758834.
Toh ZQ, Russell FM, Garland SM, Mulholland EK, Patton G, Licciardi PV (April 2021). "Human Papillomavirus Vaccination After COVID-19". JNCI Cancer Spectrum. 5 (2). Oxford University Press: pkab011. doi:10.1093/jncics/pkab011. eISSN 2515-5091. PMC 7962726. PMID 33748668. S2CID 232295180.
Daniels V, Saxena K, Roberts C, Kothari S, Corman S, Yao L, Niccolai L (May 2021). Poland G (ed.). "Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis". Vaccine. 39 (20). Elsevier: 2731–2735. doi:10.1016/j.vaccine.2021.04.003. PMC 8023201. PMID 33875269. S2CID 233034581.
Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Liu B, Bateson D, et al. (October 2014). "Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study". The Lancet. Infectious Diseases. 14 (10): 958–966. doi:10.1016/S1473-3099(14)70841-2. PMID 25107680.
Dawar DM, Harris MT, McNeil DS (January 2012). "Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) ^†". Canada Communicable Disease Report. 38 (ACS-1): 1–62. doi:10.14745/ccdr.v38i00a01. PMC 6802461. PMID 31701955. Archived from the original on 21 October 2019. Retrieved 21 October 2019.
"Boys aged 12 and 13 years to be offered HPV vaccine from September 2019, PHE announces". Pharmaceutical Journal. 303 (7927). July 2019. doi:10.1211/PJ.2019.20206777. ISSN 2053-6186. S2CID 239219776. Archived from the original on 9 August 2022.
Das M (February 2018). "Cervical cancer vaccine controversy in India". The Lancet. Oncology. 19 (2): e84. doi:10.1016/S1470-2045(18)30018-4. PMID 29413482.
Gilmour S, Kanda M, Kusumi E, Tanimoto T, Kami M, Shibuya K (August 2013). "HPV vaccination programme in Japan". Lancet. 382 (9894): 768. doi:10.1016/S0140-6736(13)61831-0. PMID 23993189. S2CID 40619281.
Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, et al. (April 2019). "HPV vaccination in Japan: what is happening in Japan?". Expert Review of Vaccines. 18 (4): 323–325. doi:10.1080/14760584.2019.1584040. PMID 30768373.
Botha MH, Dochez C (September 2012). "Introducing human papillomavirus vaccines into the health system in South Africa". Vaccine. 30 (Suppl 3): C28–C34. doi:10.1016/j.vaccine.2012.03.032. PMID 22939017.
Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, et al. (June 2021). "Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework" (PDF). Vaccine. 39 (27): 3565–3581. doi:10.1016/j.vaccine.2021.05.013. PMID 34034949. S2CID 235203871. Archived (PDF) from the original on 19 June 2022. Retrieved 8 June 2022.
"Boots launches HPV vaccination for boys and men". The Pharmaceutical Journal. 298 (7900). April 2017. doi:10.1211/PJ.2017.20202616. ISSN 2053-6186. Archived from the original on 4 July 2022.
Niccolai LM, Hansen CE (July 2015). "Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review". JAMA Pediatrics. 169 (7): 686–692. doi:10.1001/jamapediatrics.2015.0310. PMC 4862306. PMID 26010507.
Caskey R, Lindau ST, Alexander GC (November 2009). "Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey". The Journal of Adolescent Health. 45 (5): 453–462. doi:10.1016/j.jadohealth.2009.04.021. PMID 19837351. Archived from the original on 17 October 2014.
Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M (June 2013). "Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis". International Journal of Epidemiology. 42 (3): 896–908. doi:10.1093/ije/dyt049. PMC 3733698. PMID 23620381.
Schwartz JL (October 2010). "HPV vaccination's second act: promotion, competition, and compulsion". American Journal of Public Health. 100 (10): 1841–1844. doi:10.2105/AJPH.2010.193060. PMC 2936995. PMID 20724671.
Moghtaderi A, Adams S (June 2016). "The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations". Applied Health Economics and Health Policy. 14 (3): 349–359. doi:10.1007/s40258-016-0225-6. PMID 26873090. S2CID 25655517.
Budhwani H, De P (December 2017). "Human papillomavirus vaccine initiation in Asian Indians and Asian subpopulations: a case for examining disaggregated data in public health research". Public Health. 153: 111–117. doi:10.1016/j.puhe.2017.07.036. PMID 29028565.
De P, Budhwani H (March 2017). "Human papillomavirus (HPV) vaccine initiation in minority Americans". Public Health. 144: 86–91. doi:10.1016/j.puhe.2016.11.005. PMID 28274389.
Smith MJ (December 2015). "Promoting Vaccine Confidence". Infectious Disease Clinics of North America (Review). 29 (4): 759–769. doi:10.1016/j.idc.2015.07.004. PMID 26337737.
Reno JE, Dempsey AF (February 2022). "Promoting HPV vaccination among Latinx: an application of the extended parallel processing model". Journal of Behavioral Medicine. 46 (1–2): 324–334. doi:10.1007/s10865-022-00293-7. PMID 35178652. S2CID 246905792.
Brouwer AF, Delinger RL, Eisenberg MC, Campredon LP, Walline HM, Carey TE, Meza R (June 2019). "HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women". BMC Public Health. 19 (1): 821. doi:10.1186/s12889-019-7134-1. PMC 6593582. PMID 31238911.
Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT (August 2015). "Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?". Preventive Medicine. 77: 181–185. doi:10.1016/j.ypmed.2015.05.024. PMC 4490050. PMID 26051197.
Gostin LO (June 2018). "HPV Vaccination: A Public Good and a Health Imperative". The Journal of Law, Medicine & Ethics. 46 (2): 511–513. doi:10.1177/1073110518782958. PMID 30147001. S2CID 52092917.
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (February 2007). "Prevalence of HPV infection among females in the United States". JAMA. 297 (8): 813–819. doi:10.1001/jama.297.8.813. PMID 17327523.
Malmqvist E, Helgesson G, Lehtinen J, Natunen K, Lehtinen M (February 2011). "The ethics of implementing human papillomavirus vaccination in developed countries". Medicine, Health Care and Philosophy. 14 (1): 19–27. doi:10.1007/s11019-010-9285-9. PMID 20853152. S2CID 27444545.
Oberlin AM, Rahangdale L, Chinula L, Fuseini NM, Chibwesha CJ (December 2018). "Making HPV vaccination available to girls everywhere". International Journal of Gynaecology and Obstetrics. 143 (3): 267–276. doi:10.1002/ijgo.12656. PMC 6221992. PMID 30144050.
Ma B, Roden R, Wu TC (July 2010). "Current status of human papillomavirus vaccines". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 109 (7): 481–483. doi:10.1016/S0929-6646(10)60081-2. PMC 2917202. PMID 20677402.
Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, et al. (June 2009). "Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines". Journal of the National Cancer Institute. 101 (11): 782–792. doi:10.1093/jnci/djp106. PMC 2689872. PMID 19470949.
Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B (2012). "VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus". PLOS ONE. 7 (11): e49751. Bibcode:2012PLoSO...749751T. doi:10.1371/journal.pone.0049751. PMC 3501453. PMID 23185426.
van Driel WJ, Ressing ME, Brandt RM, Toes RE, Fleuren GJ, Trimbos JB, et al. (December 1996). "The current status of therapeutic HPV vaccine". Annals of Medicine. 28 (6): 471–477. doi:10.3109/07853899608999110. PMID 9017105.
Roden RB, Ling M, Wu TC (August 2004). "Vaccination to prevent and treat cervical cancer". Human Pathology. 35 (8): 971–982. doi:10.1016/j.humpath.2004.04.007. PMID 15297964.
Albarran Y, Carvajal A, de la Garza A, Cruz Quiroz BJ, Vazquez Zea E, Díaz Estrada I, et al. (2007). "MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study". BioDrugs. 21 (1): 47–59. doi:10.2165/00063030-200721010-00006. PMID 17263589. S2CID 26415621.
Corona Gutierrez CM, Tinoco A, Navarro T, Contreras ML, Cortes RR, Calzado P, et al. (May 2004). "Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus". Human Gene Therapy. 15 (5): 421–431. doi:10.1089/10430340460745757. PMID 15144573.
Singh KP, Verma N, Akhoon BA, Bhatt V, Gupta SK, Gupta SK, Smita S (June 2016). "Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains". 3 Biotech. 6 (1): 39. doi:10.1007/s13205-015-0352-z. PMC 4729761. PMID 28330110.
Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, et al. (November 2015). "Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial". Lancet. 386 (10008): 2078–2088. doi:10.1016/S0140-6736(15)00239-1. PMC 4888059. PMID 26386540.
Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C (7 October 2020). "Therapeutic Vaccines for HPV-Associated Malignancies". ImmunoTargets and Therapy. 9: 167–200. doi:10.2147/ITT.S273327. PMC 7549137. PMID 33117742.

drugs.com

"Human papillomavirus vaccine Use During Pregnancy". Drugs.com. 11 February 2019. Archived from the original on 5 April 2020. Retrieved 3 April 2020.

emaratalyoum.com

Al-Sabai W (15 September 2018). "قرار وزاري بإلزامية تطعيم سرطان عنق الرحم" [A ministerial decision mandating cervical cancer vaccination]. Emarat Alyoum (in Arabic). Archived from the original on 15 September 2018. Retrieved 16 September 2018.

emedtv.com

hpv.emedtv.com

"HPV Vaccine and Pregnancy". eMedTV. Archived from the original on 24 July 2012.

esgo.org

"ESGO Statement on Cervical Cancer Vaccination" (PDF). ESGO. 2007. Archived from the original (PDF) on 26 July 2011.

europa.eu

ema.europa.eu

"Silgard EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020.
"Gardasil 9 EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Gardasil EPAR". European Medicines Agency. 17 September 2018. Archived from the original on 11 June 2022. Retrieved 6 July 2022.
"Review concludes evidence does not support that HPV vaccines cause CRPS or POTS" (PDF) (Press release). European Medicines Agency (EMA). 5 November 2015. Archived (PDF) from the original on 14 February 2016. Retrieved 5 November 2015.
"European Medicines Agency decision P/0367/2016" (PDF). www.ema.europa.eu. European Medicines Agency. Archived from the original (PDF) on 2 November 2017. Retrieved 2 November 2017.

family.org

"Position Statement: Human Papillomavirus Vaccines". Focus on the Family. Archived from the original on 30 August 2008. Retrieved 4 January 2008.

fda.gov

"Cervarix". U.S. Food and Drug Administration (FDA). 4 October 2022. STN:BL 125259. Archived from the original on 10 October 2022. Retrieved 9 October 2022.
"FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old". U.S. Food and Drug Administration (FDA) (Press release). 5 October 2018. Archived from the original on 14 October 2019. Retrieved 14 October 2018.
"FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old". U.S. Food and Drug Administration. Archived from the original on 14 October 2019. Retrieved 9 November 2019.
"FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on 24 October 2009. Retrieved 30 October 2009.
"FDA: Gardasil approved to prevent anal cancer" (Press release). U.S. Food and Drug Administration (FDA). 2010. Archived from the original on 18 December 2014. Retrieved 15 January 2015.
"Gardasil". U.S. Food and Drug Administration (FDA). 25 April 2019. STN 125126. Archived from the original on 15 October 2019. Retrieved 15 October 2019.
"Gardasil 9". U.S. Food and Drug Administration (FDA). 25 April 2019. STN 125508. Archived from the original on 15 October 2019. Retrieved 15 October 2019.
Montague L (5 October 2018). "Summary Basis for Regulatory Action" (PDF). U.S. Food and Drug Administration (FDA). Archived from the original on 14 December 2019. Retrieved 7 August 2019.
"FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus" (Press release). U.S. Food and Drug Administration (FDA). 8 June 2006. Archived from the original on 19 October 2009. Retrieved 13 November 2009.
"16 October 2009 Approval Letter – Cervarix". U.S. Food and Drug Administration (FDA). 16 October 2009. Archived from the original on 19 October 2009. Retrieved 13 November 2009.
"FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV" (press release). U.S. Food and Drug Administration (FDA). 10 December 2014. Archived from the original on 10 January 2015. Retrieved 9 January 2015.

folkhalsomyndigheten.se

"Vaccination programmes". Folkhälsomyndigheten. The Public Health Agency of Sweden. 18 February 2022. Archived from the original on 12 July 2022. Retrieved 26 November 2022.
"Statistik för HPV-vaccinationer — Folkhälsomyndigheten". Folkhälsomyndigheten (in Swedish). 14 May 2022. Archived from the original on 2 June 2022. Retrieved 26 November 2022.
"Vaccin mot humant papillomvirus (HPV) — Folkhälsomyndigheten". Folkhälsomyndigheten (in Swedish). 21 February 2022. Archived from the original on 26 October 2022. Retrieved 26 November 2022.

forbes.com

Haelle T (23 February 2016). "HPV Infection Rates Plummet In Young Women Due To Vaccine". Forbes. Archived from the original on 26 February 2016. Retrieved 23 February 2016.

frc.org

"IF07B01". Family Research Council. 7 February 2008. Archived from the original on 4 August 2007.

fskilkis.gr

"The vaccine against cervical cancer and Cervarix vs Gardasil" (in Greek). 12 February 2008. Archived from the original on 13 June 2013. Retrieved 10 August 2013.

gavialliance.org

Frazer I. "Human papillomavirus vaccine – New and underused vaccines support – Types of support". GAVI Alliance. Archived from the original on 18 January 2014. Retrieved 29 December 2013.

getfilings.com

"Virolab, Inc. – FORM 8-K/A". Getfilings.com. 24 June 2011. Archived from the original on 3 December 2013. Retrieved 29 December 2013.

gov.uk

"JCVI statement: extending the HPV vaccination programme – conclusions". GOV.UK. Archived from the original on 4 January 2019. Retrieved 4 January 2019.
"Human papillomavirus (HPV): the green book, chapter 18a". Public Health England. 20 March 2013. Archived from the original on 15 October 2019. Retrieved 3 January 2019.

gsk-china.com

"GSK announces Cervarix approved in China to help protect women from cervical cancer". GlaxoSmithKline (Press release). 18 July 2016. Archived from the original on 24 July 2016. Retrieved 20 October 2019.
"Cervarix is approved for cervical cancer prevention in female population aged 9-45 years in mainland China". GlaxoSmithKline (Press release). 29 May 2018. Archived from the original on 31 March 2019. Retrieved 20 October 2019.
"Cervarix, first vaccine for cervical cancer prevention in mainland China, has officially launched". GlaxoSmithKline (Press release). 31 July 2017. Archived from the original on 4 September 2017. Retrieved 20 October 2019.

gsk-vap.com

"Patient Eligibility". GSK Vaccine Access Program. GlaxoSmithKline. Archived from the original on 9 April 2016.

gskforyou.com

"Patient Assistance for Vaccines | GSKForYou". www.gskforyou.com. Archived from the original on 15 July 2016. Retrieved 16 October 2019.
"GSK Vaccines Access Program". Archived from the original on 21 August 2016. Retrieved 16 October 2019.

gulfnews.com

D'Souza C (24 April 2013). "Cervical cancer vaccination could be mandatory in UAE". Gulf News. Archived from the original on 16 September 2018. Retrieved 16 September 2018.

gulftoday.ae

Al Ali I (15 September 2018). "Cervical cancer vaccination for Dubai schools". Gulf Today. Archived from the original on 15 September 2018. Retrieved 16 September 2018.

haad.ae

"Prevention". Archived from the original on 16 September 2018. Retrieved 16 September 2018.

handle.net

hdl.handle.net

World Health Organization (December 2022). "Human papillomavirus vaccines: WHO position paper (2022 update)". Weekly Epidemiological Record. 97 (50): 645–672. hdl:10665/365351.
World Health Organization (May 2011). The immunological basis for immunization series: module 19: human papillomavirus infection. World Health Organization. hdl:10665/44604. ISBN 9789241501590.
World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
Thompson EL, Livingston MD, Daley EM, Saslow D, Zimet GD (August 2020). "Rhode Island Human Papillomavirus Vaccine School Entry Requirement Using Provider-Verified Report". American Journal of Preventive Medicine. 59 (2): 274–277. doi:10.1016/j.amepre.2020.02.022. hdl:1805/28509. PMID 32430223. S2CID 218758834.

harvard.edu

ui.adsabs.harvard.edu

Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B (2012). "VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus". PLOS ONE. 7 (11): e49751. Bibcode:2012PLoSO...749751T. doi:10.1371/journal.pone.0049751. PMC 3501453. PMID 23185426.

health.gov.au

immunise.health.gov.au

"Information about the HPV immunisation program". The Immunise Australia Program. Department of Health, Commonwealth of Australia. Archived from the original on 4 May 2015.

health.gov.au

"Historical Human Papillomavirus (HPV) immunisation coverage rates". Australian Government Department of Health. 4 December 2019. Archived from the original on 28 September 2021. Retrieved 28 September 2021.

health.gov.il

"health.gov.il". Ministry of Health. Israel. Archived from the original on 29 October 2013.

health.govt.nz

"Questions and answers about HPV immunisation". Ministry of Health NZ. 29 September 2021. Archived from the original on 26 February 2018. Retrieved 24 November 2021.

hpsc.ie

"HSPC HPV vaccine uptake in Ireland" (PDF). Archived from the original (PDF) on 11 January 2019. Retrieved 16 October 2019.

hse.ie

"HPV". HSE.ie. Archived from the original on 12 January 2019. Retrieved 11 January 2019.

huffingtonpost.com

Yerman MG (28 December 2009). "An Interview with Dr. Diane M. Harper, HPV Expert". Huffington Post. Archived from the original on 13 August 2013. Retrieved 28 August 2013.

iatronet.gr

Karakitsos P (7 March 2008). "Vaccination against HPV in Greece" (in Greek). Archived from the original on 30 April 2013. Retrieved 10 August 2013.

immunizationforwomen.org

"ACA Preventative Services Benefits for Women and Pregnant Women". Immunization for Women. Archived from the original on 9 September 2013. Retrieved 10 August 2013.

inovio.com

ir.inovio.com

"Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer". www.inovio.com. Inovio Pharmaceuticals. Archived from the original on 2 November 2017. Retrieved 2 November 2017.

iol.co.za

SAPA (15 May 2013). "Schoolgirls to get cancer vaccine". ioL News. Archived from the original on 12 August 2013. Retrieved 7 August 2013.

irishtimes.com

Cullen P. "HPV vaccine to be offered to boys from start of school year in 2019". The Irish Times. Archived from the original on 4 September 2019. Retrieved 16 October 2019.
"Irish times- HPV vaccine to be offered to boys from start of school year in 2019". The Irish Times. Archived from the original on 8 December 2018. Retrieved 11 January 2019.

jiji.com

sp.m.jiji.com

"Japan to Resume Active Promotion of HPV Vaccinations in April". Jiji Press News. 26 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.

jpost.com

Siegel J (9 October 2013). "Health Ministry decides to offer free HPV vaccine to 13-year-old girls | JPost | Israel News". JPost. Archived from the original on 2 December 2013. Retrieved 29 December 2013.

kaisernetwork.org

"Detroit News Examines Cost of HPV Vaccine Gardasil". Kaiser Family Foundation. 29 March 2007. Archived from the original on 15 October 2007.

kbv.de

"HPV-Impfung jetzt auch für Jungen Kassenleistung" (in German). Kassenärztliche Vereinigung. 6 December 2018. Archived from the original on 1 December 2020. Retrieved 18 November 2020.

kff.org

"The HPV Vaccine: Access and Use in the U.S." The Henry J. Kaiser Family Foundation. 12 July 2021. Archived from the original on 31 December 2022. Retrieved 1 January 2023.

khaleejtimes.com

"UAE gets cervical cancer vaccine". Khaleej Times. 7 January 2007. Archived from the original on 17 September 2018. Retrieved 17 September 2018.

kukinews.com

news.kukinews.com

"[기획] 어린이 자궁경부암 예방접종 무료…가다실 Vs 서바릭스 어떤 백신 도입될까". 18 January 2016. Archived from the original on 3 February 2016. Retrieved 27 January 2016.

lenus.ie

"HSE Guidelines for staff HPV second level school vaccination campaign" (PDF). Archived (PDF) from the original on 11 January 2019. Retrieved 16 October 2019.

livescience.com

Rettner R (25 October 2011). "Boys Should Get HPV Vaccine Too, CDC Says". LiveScience. Archived from the original on 3 July 2012. Retrieved 11 November 2011.

mainichi.jp

"Japan to allow free HPV vaccines to women born FY1997-2005 after 8-year hiatus". Mainichi Shimbun. 24 December 2021. Archived from the original on 28 December 2021. Retrieved 28 December 2021.

medicalnewstoday.com

"Cervarix Marketing in Kenya". Medical News Today. Archived from the original on 3 January 2009. Retrieved 17 September 2010.

medicines.org.uk

"Gardasil 9 suspension for injection - Summary of Product Characteristics (SmPC)". (emc). 24 January 2020. Archived from the original on 6 April 2020. Retrieved 3 April 2020.
"Gardasil suspension for injection - Summary of Product Characteristics (SmPC)". (emc). 7 May 2019. Archived from the original on 4 April 2020. Retrieved 3 April 2020.

medscape.com

Mulcahy N (25 June 2013). "Japan Withdraws HPV Vaccine Recommendation for Girls". Medscape. Archived from the original on 23 April 2020. Retrieved 17 May 2020.

merck.com

"Merck Reports Double-Digit Earnings-Per-Share Growth for Second Quarter 2007" (Press release). Archived from the original on 12 October 2007. Retrieved 16 October 2019.

merckhelps.com

"Merck Programs to Help Those in Need - Programs". www.merckhelps.com. Archived from the original on 5 June 2016. Retrieved 16 October 2019.

merckpregnancyregistries.com

"Gardasil Pregnancy Registry". Merck & Co. 1 February 2012. Archived from the original on 1 March 2012. Retrieved 29 May 2007.
"Gardasil 9 Pregnancy Registry". Merck & Co. Archived from the original on 28 August 2018. Retrieved 21 October 2019.

mg.co.za

Green A (7 June 2013). "Life saving cancer vaccine will be difficult to implement". Mail & Guardian. Archived from the original on 17 July 2013. Retrieved 7 August 2013.

mhlw.go.jp

"HPVワクチンに関する調査結果等について Survey results, etc. regarding HPV vaccines" (PDF). Ministry of Health, Labour and Welfare of Japan. 1 August 2023. Retrieved 2 August 2023.
"HPV ワクチンの接種状況に関する検討 HPV Consideration of HPV vaccination status" (PDF). Ministry of Health, Labour and Welfare of Japan. 26 June 2024. Retrieved 20 February 2024.

minsalud.gov.co

"ABC VPH vaccine". www.minsalud.gov.co. Archived from the original on 4 August 2015. Retrieved 29 July 2015.

missouri.edu

ciitn.missouri.edu

"leftside". Ciitn.missouri.edu. 22 January 2007. Archived from the original on 2 October 2013. Retrieved 29 December 2013.

msd-korea.com

"가다실 제품 허가 공지". 27 June 2007. Archived from the original on 29 September 2007. Retrieved 6 August 2007.

msmagazine.com

"Lifesaving Politics". Ms. Spring 2007. pp. 12–13. Archived from the original on 1 June 2007.

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

"HPV vaccination programme switching to Gardasil from September 2012". immunisation.dh.gov.uk. Department of Health. 28 November 2011. Archived from the original on 4 January 2013. Retrieved 3 January 2019.

ncirs.edu.au

"Human papillomavirus (HPV) vaccines for Australians" (PDF). National Centre for Immunisation Research and Surveillance Factsheet. March 2013. Archived from the original (PDF) on 20 April 2013.

ncsl.org

"States With Religious and Philosophical Exemptions From School Immunization Requirements". National Conference of State Legislatures. 25 May 2022. Retrieved 2 January 2023.

newstandardnews.net

Coyne B (2 November 2005). "Cervical Cancer Vaccine Raises 'Promiscuity' Controversy". The New Standard. Archived from the original on 7 August 2006. Retrieved 28 August 2006.

nhs.uk

"HPV vaccine overview". nhs.uk. 31 July 2019. Archived from the original on 1 January 2019. Retrieved 5 February 2022.
"HPV vaccine". nhs.uk. 9 May 2018. Archived from the original on 1 January 2019. Retrieved 3 January 2019.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kash N, Lee MA, Kollipara R, Downing C, Guidry J, Tyring SK (April 2015). "Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus". Journal of Clinical Medicine. 4 (4): 614–633. doi:10.3390/jcm4040614. PMC 4470159. PMID 26239350. S2CID 14149551.
De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (April 2009). "Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis". International Journal of Cancer. 124 (7): 1626–1636. doi:10.1002/ijc.24116. PMID 19115209. S2CID 24197494.
Takes RP, Wierzbicka M, D'Souza G, Jackowska J, Silver CE, Rodrigo JP, et al. (December 2015). "HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?". Oral Oncology. 51 (12): 1057–1060. doi:10.1016/j.oraloncology.2015.10.011. PMID 26520047. S2CID 23356354.
Thaxton L, Waxman AG (May 2015). "Cervical cancer prevention: immunization and screening 2015". The Medical Clinics of North America. 99 (3): 469–477. doi:10.1016/j.mcna.2015.01.003. PMID 25841595. S2CID 2828633.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". StatPearls (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
Saville AM (April 2016). "Cervical cancer prevention in Australia: Planning for the future". Cancer Cytopathology. 124 (4): 235–240. doi:10.1002/cncy.21643. PMID 26619381.
Hotez PJ, Bottazzi ME (January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55–64. doi:10.1146/annurev-med-042420-113212. PMID 34637324. S2CID 238747462.
Fesenfeld M, Hutubessy R, Jit M (August 2013). "Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review". Vaccine. 31 (37): 3786–3804. doi:10.1016/j.vaccine.2013.06.060. PMID 23830973.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (August 2019). "Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (32): 698–702. doi:10.15585/mmwr.mm6832a3. PMC 6818701. PMID 31415491. Archived (PDF) from the original on 13 October 2019. Retrieved 15 October 2019.
Drolet M, Bénard É, Pérez N, Brisson M (August 2019). "Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis". Lancet. 394 (10197): 497–509. doi:10.1016/S0140-6736(19)30298-3. PMC 7316527. PMID 31255301.
Cox B, Sneyd MJ (2018). "HPV screening, invasive cervical cancer and screening policy in Australia". Journal of the American Society of Cytopathology. 7 (6): 292–299. doi:10.1016/j.jasc.2018.07.003. PMID 31043298. S2CID 58548623.
Lew JB, Simms KT, Smith MA, Hall M, Kang YJ, Xu XM, et al. (February 2017). "Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program". The Lancet. Public Health. 2 (2): e96–e107. doi:10.1016/S2468-2667(17)30007-5. PMID 29253402.
Arbyn M, Xu L, Simoens C, Martin-Hirsch PP (May 2018). "Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors". The Cochrane Database of Systematic Reviews. 5 (3): CD009069. doi:10.1002/14651858.CD009069.pub3. PMC 4176676. PMID 29740819. CD009069.
Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. (April 2006). "Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial". Lancet. 367 (9518): 1247–1255. doi:10.1016/S0140-6736(06)68439-0. PMID 16631880. S2CID 18685310.
De Vincenzo R, Conte C, Ricci C, Scambia G, Capelli G (3 December 2014). "Long-term efficacy and safety of human papillomavirus vaccination". International Journal of Women's Health. 6: 999–1010. doi:10.2147/IJWH.S50365. PMC 4262378. PMID 25587221.
"Committee opinion no. 467: human papillomavirus vaccination". Obstetrics and Gynecology. 116 (3): 800–803. September 2010. doi:10.1097/AOG.0b013e3181f680c8. PMID 20733476.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (March 2007). "Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 56 (RR-2): 1–24. PMID 17380109. Archived (PDF) from the original on 24 September 2015.
|Tay SK (February 2012). "Cervical cancer in the human papillomavirus vaccination era". Current Opinion in Obstetrics & Gynecology. 24 (1): 3–7. doi:10.1097/GCO.0b013e32834daed9. PMID 22123221. S2CID 23213383.
Jit M, Brisson M, Laprise JF, Choi YH (January 2015). "Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model". BMJ. 350: g7584. doi:10.1136/bmj.g7584. PMC 4285892. PMID 25567037.
Sonawane K, Nyitray AG, Nemutlu GS, Swartz MD, Chhatwal J, Deshmukh AA (December 2019). "Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women". JAMA Network Open. 2 (12): e1918571. doi:10.1001/jamanetworkopen.2019.18571. PMC 6986697. PMID 31880792.
Zou Z, Zhang L (October 2023). "The one-dose schedule opens the door to rapid scale-up of HPV vaccination". BMC Medicine. 21 (1): 387. doi:10.1186/s12916-023-03097-x. PMC 10561457. PMID 37807059.
Markowitz LE, Unger ER (May 2023). "Human Papillomavirus Vaccination". The New England Journal of Medicine. 388 (19): 1790–1798. doi:10.1056/NEJMcp2108502. PMID 37163625. S2CID 264642213.
Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, et al. (February 2015). "A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women". The New England Journal of Medicine. 372 (8): 711–723. doi:10.1056/NEJMoa1405044. PMID 25693011.
Schuchat A (February 2015). "HPV "coverage"". The New England Journal of Medicine. 372 (8): 775–776. doi:10.1056/NEJMe1415742. PMC 6009818. PMID 25693018.
Centers for Disease Control and Prevention (CDC) (May 2010). "FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Morbidity and Mortality Weekly Report. 59 (20): 630–632. PMID 20508594. Archived (PDF) from the original on 24 September 2015.
Chow EP, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, et al. (December 2021). "Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18". The Lancet. Infectious Diseases. 21 (12): 1747–1756. doi:10.1016/S1473-3099(21)00071-2. PMID 34339639. S2CID 236884872.
Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK (May 2015). "Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme". Sexually Transmitted Infections. 91 (3): 214–219. doi:10.1136/sextrans-2014-051813. PMID 25305210. S2CID 24549759.
Chow EP, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Garland SM, et al. (October 2021). "Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study". The Lancet. Infectious Diseases. 21 (10): 1448–1457. doi:10.1016/S1473-3099(20)30687-3. PMID 34043963. S2CID 235230838.
Chow EP, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, et al. (January 2017). "Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study". The Lancet. Infectious Diseases. 17 (1): 68–77. doi:10.1016/S1473-3099(16)30116-5. PMID 27282422.
Castle PE, Scarinci I (October 2009). "Should HPV vaccine be given to men?". BMJ. 339 (7726): b4127. doi:10.1136/bmj.b4127. PMID 19815585. S2CID 1922594.
Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al. (August 2004). "Against which human papillomavirus types shall we vaccinate and screen? The international perspective". International Journal of Cancer. 111 (2): 278–285. doi:10.1002/ijc.20244. PMID 15197783. S2CID 20679802.
Wittet S, Tsu V (June 2008). "Cervical cancer prevention and the Millennium Development Goals". Bulletin of the World Health Organization. 86 (6): 488–490. doi:10.2471/BLT.07.050450. PMC 2647477. PMID 18568279.
Moghtaderi A, Dor A (April 2021). "Immunization and Moral Hazard: The HPV Vaccine and Uptake of Cancer Screening". Medical Care Research and Review. 78 (2): 125–137. doi:10.3386/w22523. PMID 31096862.
Goss MA, Lievano F, Buchanan KM, Seminack MM, Cunningham ML, Dana A (June 2015). "Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine". Vaccine. 33 (29): 3422–3428. doi:10.1016/j.vaccine.2015.04.014. PMID 25869893.
Lowy DR, Schiller JT (May 2006). "Prophylactic human papillomavirus vaccines". The Journal of Clinical Investigation. 116 (5): 1167–1173. doi:10.1172/JCI28607. PMC 1451224. PMID 16670757.
McNeil C (April 2006). "Who invented the VLP cervical cancer vaccines?". Journal of the National Cancer Institute. 98 (7): 433. doi:10.1093/jnci/djj144. PMID 16595773.
Kim JJ, Goldie SJ (October 2009). "Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States". BMJ. 339 (7726): b3884. doi:10.1136/bmj.b3884. PMC 2759438. PMID 19815582.
Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. (September 2007). "Human papillomavirus and HPV vaccines: a review". Bulletin of the World Health Organization. 85 (9): 719–726. doi:10.2471/BLT.06.038414. PMC 2636411. PMID 18026629.
Ko JS, Goldbeck CS, Baughan EB, Klausner JD (September 2020). "Association Between Human Papillomavirus Vaccination School-Entry Requirements and Vaccination Initiation". JAMA Pediatrics. 174 (9): 861–867. doi:10.1001/jamapediatrics.2020.1852. PMC 7325070. PMID 32597928.
Thompson EL, Livingston MD, Daley EM, Saslow D, Zimet GD (August 2020). "Rhode Island Human Papillomavirus Vaccine School Entry Requirement Using Provider-Verified Report". American Journal of Preventive Medicine. 59 (2): 274–277. doi:10.1016/j.amepre.2020.02.022. hdl:1805/28509. PMID 32430223. S2CID 218758834.
Toh ZQ, Russell FM, Garland SM, Mulholland EK, Patton G, Licciardi PV (April 2021). "Human Papillomavirus Vaccination After COVID-19". JNCI Cancer Spectrum. 5 (2). Oxford University Press: pkab011. doi:10.1093/jncics/pkab011. eISSN 2515-5091. PMC 7962726. PMID 33748668. S2CID 232295180.
Daniels V, Saxena K, Roberts C, Kothari S, Corman S, Yao L, Niccolai L (May 2021). Poland G (ed.). "Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis". Vaccine. 39 (20). Elsevier: 2731–2735. doi:10.1016/j.vaccine.2021.04.003. PMC 8023201. PMID 33875269. S2CID 233034581.
Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Liu B, Bateson D, et al. (October 2014). "Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study". The Lancet. Infectious Diseases. 14 (10): 958–966. doi:10.1016/S1473-3099(14)70841-2. PMID 25107680.
Dawar DM, Harris MT, McNeil DS (January 2012). "Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) ^†". Canada Communicable Disease Report. 38 (ACS-1): 1–62. doi:10.14745/ccdr.v38i00a01. PMC 6802461. PMID 31701955. Archived from the original on 21 October 2019. Retrieved 21 October 2019.
Das M (February 2018). "Cervical cancer vaccine controversy in India". The Lancet. Oncology. 19 (2): e84. doi:10.1016/S1470-2045(18)30018-4. PMID 29413482.
Gilmour S, Kanda M, Kusumi E, Tanimoto T, Kami M, Shibuya K (August 2013). "HPV vaccination programme in Japan". Lancet. 382 (9894): 768. doi:10.1016/S0140-6736(13)61831-0. PMID 23993189. S2CID 40619281.
Ikeda S, Ueda Y, Yagi A, Matsuzaki S, Kobayashi E, Kimura T, et al. (April 2019). "HPV vaccination in Japan: what is happening in Japan?". Expert Review of Vaccines. 18 (4): 323–325. doi:10.1080/14760584.2019.1584040. PMID 30768373.
Botha MH, Dochez C (September 2012). "Introducing human papillomavirus vaccines into the health system in South Africa". Vaccine. 30 (Suppl 3): C28–C34. doi:10.1016/j.vaccine.2012.03.032. PMID 22939017.
Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, et al. (June 2021). "Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework" (PDF). Vaccine. 39 (27): 3565–3581. doi:10.1016/j.vaccine.2021.05.013. PMID 34034949. S2CID 235203871. Archived (PDF) from the original on 19 June 2022. Retrieved 8 June 2022.
Niccolai LM, Hansen CE (July 2015). "Practice- and Community-Based Interventions to Increase Human Papillomavirus Vaccine Coverage: A Systematic Review". JAMA Pediatrics. 169 (7): 686–692. doi:10.1001/jamapediatrics.2015.0310. PMC 4862306. PMID 26010507.
Caskey R, Lindau ST, Alexander GC (November 2009). "Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey". The Journal of Adolescent Health. 45 (5): 453–462. doi:10.1016/j.jadohealth.2009.04.021. PMID 19837351. Archived from the original on 17 October 2014.
Fisher H, Trotter CL, Audrey S, MacDonald-Wallis K, Hickman M (June 2013). "Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis". International Journal of Epidemiology. 42 (3): 896–908. doi:10.1093/ije/dyt049. PMC 3733698. PMID 23620381.
Schwartz JL (October 2010). "HPV vaccination's second act: promotion, competition, and compulsion". American Journal of Public Health. 100 (10): 1841–1844. doi:10.2105/AJPH.2010.193060. PMC 2936995. PMID 20724671.
Moghtaderi A, Adams S (June 2016). "The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations". Applied Health Economics and Health Policy. 14 (3): 349–359. doi:10.1007/s40258-016-0225-6. PMID 26873090. S2CID 25655517.
Budhwani H, De P (December 2017). "Human papillomavirus vaccine initiation in Asian Indians and Asian subpopulations: a case for examining disaggregated data in public health research". Public Health. 153: 111–117. doi:10.1016/j.puhe.2017.07.036. PMID 29028565.
De P, Budhwani H (March 2017). "Human papillomavirus (HPV) vaccine initiation in minority Americans". Public Health. 144: 86–91. doi:10.1016/j.puhe.2016.11.005. PMID 28274389.
Smith MJ (December 2015). "Promoting Vaccine Confidence". Infectious Disease Clinics of North America (Review). 29 (4): 759–769. doi:10.1016/j.idc.2015.07.004. PMID 26337737.
Reno JE, Dempsey AF (February 2022). "Promoting HPV vaccination among Latinx: an application of the extended parallel processing model". Journal of Behavioral Medicine. 46 (1–2): 324–334. doi:10.1007/s10865-022-00293-7. PMID 35178652. S2CID 246905792.
Brouwer AF, Delinger RL, Eisenberg MC, Campredon LP, Walline HM, Carey TE, Meza R (June 2019). "HPV vaccination has not increased sexual activity or accelerated sexual debut in a college-aged cohort of men and women". BMC Public Health. 19 (1): 821. doi:10.1186/s12889-019-7134-1. PMC 6593582. PMID 31238911.
Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT (August 2015). "Physician communication about adolescent vaccination: How is human papillomavirus vaccine different?". Preventive Medicine. 77: 181–185. doi:10.1016/j.ypmed.2015.05.024. PMC 4490050. PMID 26051197.
Gostin LO (June 2018). "HPV Vaccination: A Public Good and a Health Imperative". The Journal of Law, Medicine & Ethics. 46 (2): 511–513. doi:10.1177/1073110518782958. PMID 30147001. S2CID 52092917.
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (February 2007). "Prevalence of HPV infection among females in the United States". JAMA. 297 (8): 813–819. doi:10.1001/jama.297.8.813. PMID 17327523.
Malmqvist E, Helgesson G, Lehtinen J, Natunen K, Lehtinen M (February 2011). "The ethics of implementing human papillomavirus vaccination in developed countries". Medicine, Health Care and Philosophy. 14 (1): 19–27. doi:10.1007/s11019-010-9285-9. PMID 20853152. S2CID 27444545.
Oberlin AM, Rahangdale L, Chinula L, Fuseini NM, Chibwesha CJ (December 2018). "Making HPV vaccination available to girls everywhere". International Journal of Gynaecology and Obstetrics. 143 (3): 267–276. doi:10.1002/ijgo.12656. PMC 6221992. PMID 30144050.
Ma B, Roden R, Wu TC (July 2010). "Current status of human papillomavirus vaccines". Journal of the Formosan Medical Association = Taiwan Yi Zhi. 109 (7): 481–483. doi:10.1016/S0929-6646(10)60081-2. PMC 2917202. PMID 20677402.
Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, et al. (June 2009). "Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines". Journal of the National Cancer Institute. 101 (11): 782–792. doi:10.1093/jnci/djp106. PMC 2689872. PMID 19470949.
Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B (2012). "VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus". PLOS ONE. 7 (11): e49751. Bibcode:2012PLoSO...749751T. doi:10.1371/journal.pone.0049751. PMC 3501453. PMID 23185426.
van Driel WJ, Ressing ME, Brandt RM, Toes RE, Fleuren GJ, Trimbos JB, et al. (December 1996). "The current status of therapeutic HPV vaccine". Annals of Medicine. 28 (6): 471–477. doi:10.3109/07853899608999110. PMID 9017105.
Roden RB, Ling M, Wu TC (August 2004). "Vaccination to prevent and treat cervical cancer". Human Pathology. 35 (8): 971–982. doi:10.1016/j.humpath.2004.04.007. PMID 15297964.
Albarran Y, Carvajal A, de la Garza A, Cruz Quiroz BJ, Vazquez Zea E, Díaz Estrada I, et al. (2007). "MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study". BioDrugs. 21 (1): 47–59. doi:10.2165/00063030-200721010-00006. PMID 17263589. S2CID 26415621.
Corona Gutierrez CM, Tinoco A, Navarro T, Contreras ML, Cortes RR, Calzado P, et al. (May 2004). "Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus". Human Gene Therapy. 15 (5): 421–431. doi:10.1089/10430340460745757. PMID 15144573.
Singh KP, Verma N, Akhoon BA, Bhatt V, Gupta SK, Gupta SK, Smita S (June 2016). "Sequence-based approach for rapid identification of cross-clade CD8+ T-cell vaccine candidates from all high-risk HPV strains". 3 Biotech. 6 (1): 39. doi:10.1007/s13205-015-0352-z. PMC 4729761. PMID 28330110.
Trimble CL, Morrow MP, Kraynyak KA, Shen X, Dallas M, Yan J, et al. (November 2015). "Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial". Lancet. 386 (10008): 2078–2088. doi:10.1016/S0140-6736(15)00239-1. PMC 4888059. PMID 26386540.
Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C (7 October 2020). "Therapeutic Vaccines for HPV-Associated Malignancies". ImmunoTargets and Therapy. 9: 167–200. doi:10.2147/ITT.S273327. PMC 7549137. PMID 33117742.

nippon.com

"Japan to Give Free HPV Vaccinations to Those Who Missed Them". nippon.com. 15 November 2021. Archived from the original on 15 November 2021. Retrieved 4 February 2022.

npr.org

Knox R (19 June 2013). "Vaccine Against HPV Has Cut Infections In Teenage Girls". NPR. Archived from the original on 20 June 2013. Retrieved 21 June 2013.

nwcn.com

"Green card seekers won't have to get HPV vaccine". 16 November 2009. Archived from the original on 27 September 2011. Retrieved 31 January 2011.

nytimes.com

Rosenthal E (19 August 2008). "Drug Makers' Push Leads to Cancer Vaccines' Fast Rise". The New York Times. Archived from the original on 9 April 2009. Retrieved 20 August 2008. Said Dr. Raffle, the British cervical cancer specialist: 'Oh, dear. If we give it to boys, then all pretense of scientific worth and cost analysis goes out the window.'
McNeil Jr DG (5 May 2013). "Cancer Vaccines Get a Price Cut in Poor Nations". The New York Times. Archived from the original on 23 November 2013. Retrieved 23 November 2013.
Gabriel T, Grady D (13 September 2011). "Rick Perry Under Fire by Republican Rivals for Requiring HPV Vaccine for Girls". The New York Times. Archived from the original on 14 September 2011. Retrieved 22 February 2017.

omaha.com

"CDC panel recommends HPV vaccine for boys, too". 26 October 2011. Archived from the original on 5 September 2012.

partnershipagainstcancer.ca

"HPV vaccine access in Canada, 2022". Canadian Partnership Against Cancer. November 2022. Retrieved 11 January 2023.

patents.google.com

U.S. patent 7,476,389, titled "Papilloma Virus Vaccines", was granted to co-inventors Ian Frazer and Jian Zhou (Zhou posthumously) on 13 January 2009. Its U.S. application was filed on 19 January 1994, but claimed priority under a 20 July 1992, PTC filing to the date of an initial [AU] Australian patent application filed on 19 July 1991.

pbs.gov.au

"Pharmaceutical Benefits Scheme (PBS) | Recommendations made by the PBAC - November 2011". Australian Government Department of Health. Archived from the original on 19 April 2013.

pharmaceutical-journal.com

"Boys aged 12 and 13 years to be offered HPV vaccine from September 2019, PHE announces". Pharmaceutical Journal. 303 (7927). July 2019. doi:10.1211/PJ.2019.20206777. ISSN 2053-6186. S2CID 239219776. Archived from the original on 9 August 2022.
"Boots launches HPV vaccination for boys and men". The Pharmaceutical Journal. 298 (7900). April 2017. doi:10.1211/PJ.2017.20202616. ISSN 2053-6186. Archived from the original on 4 July 2022.

pocahontascoia.us

pcph.pocahontascoia.us

"Human Papillomavirus (HPV) Vaccine Recommendations" (PDF). FDA. Archived from the original (PDF) on 7 March 2014.

poz.com

Highleyman L (3 September 2021). "Get HPV Vaccination Back on Track, Experts Urge". POZ. New York City. ISSN 1075-5705. Archived from the original on 8 September 2021. Retrieved 8 September 2021.

rapportian.com

"[자궁경부'앎'은 힘이다! - 가다실] "자궁경부암 백신 무료접종으로 공중보건 질적 향상 기대" - 라포르시안". rapportian.com. 5 April 2016. Archived from the original on 28 August 2021. Retrieved 7 May 2018.

reuters.com

"Glaxo prepares to launch Cervarix after EU okay". Reuters. 24 September 2007. Archived from the original on 25 October 2008. Retrieved 18 July 2008.

ri.gov

health.ri.gov

"Immunization Information for Schools & Childcare Providers: Department of Health". www.health.ri.gov. Archived from the original on 21 November 2015. Retrieved 20 November 2015.

ripr.org

"Opposition To HPV Vaccine Stirs Passion, Bewilderment". ripr.org. 17 September 2015. Archived from the original on 21 November 2015. Retrieved 20 November 2015.

rokotustieto.fi

"HPV vaccine will now also be offered to boys". Lääketietokeskus. 20 May 2020. Archived from the original on 9 August 2020. Retrieved 3 September 2020.

semanticscholar.org

api.semanticscholar.org

Kash N, Lee MA, Kollipara R, Downing C, Guidry J, Tyring SK (April 2015). "Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus". Journal of Clinical Medicine. 4 (4): 614–633. doi:10.3390/jcm4040614. PMC 4470159. PMID 26239350. S2CID 14149551.
De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (April 2009). "Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis". International Journal of Cancer. 124 (7): 1626–1636. doi:10.1002/ijc.24116. PMID 19115209. S2CID 24197494.
Takes RP, Wierzbicka M, D'Souza G, Jackowska J, Silver CE, Rodrigo JP, et al. (December 2015). "HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?". Oral Oncology. 51 (12): 1057–1060. doi:10.1016/j.oraloncology.2015.10.011. PMID 26520047. S2CID 23356354.
Thaxton L, Waxman AG (May 2015). "Cervical cancer prevention: immunization and screening 2015". The Medical Clinics of North America. 99 (3): 469–477. doi:10.1016/j.mcna.2015.01.003. PMID 25841595. S2CID 2828633.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". StatPearls (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
Hotez PJ, Bottazzi ME (January 2022). "Whole Inactivated Virus and Protein-Based COVID-19 Vaccines". Annual Review of Medicine. 73 (1): 55–64. doi:10.1146/annurev-med-042420-113212. PMID 34637324. S2CID 238747462.
Cox B, Sneyd MJ (2018). "HPV screening, invasive cervical cancer and screening policy in Australia". Journal of the American Society of Cytopathology. 7 (6): 292–299. doi:10.1016/j.jasc.2018.07.003. PMID 31043298. S2CID 58548623.
Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. (April 2006). "Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial". Lancet. 367 (9518): 1247–1255. doi:10.1016/S0140-6736(06)68439-0. PMID 16631880. S2CID 18685310.
|Tay SK (February 2012). "Cervical cancer in the human papillomavirus vaccination era". Current Opinion in Obstetrics & Gynecology. 24 (1): 3–7. doi:10.1097/GCO.0b013e32834daed9. PMID 22123221. S2CID 23213383.
Markowitz LE, Unger ER (May 2023). "Human Papillomavirus Vaccination". The New England Journal of Medicine. 388 (19): 1790–1798. doi:10.1056/NEJMcp2108502. PMID 37163625. S2CID 264642213.
Chow EP, Carter A, Vickers T, Fairley CK, McNulty A, Guy RJ, et al. (December 2021). "Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004-18". The Lancet. Infectious Diseases. 21 (12): 1747–1756. doi:10.1016/S1473-3099(21)00071-2. PMID 34339639. S2CID 236884872.
Chow EP, Read TR, Wigan R, Donovan B, Chen MY, Bradshaw CS, Fairley CK (May 2015). "Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme". Sexually Transmitted Infections. 91 (3): 214–219. doi:10.1136/sextrans-2014-051813. PMID 25305210. S2CID 24549759.
Chow EP, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Garland SM, et al. (October 2021). "Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study". The Lancet. Infectious Diseases. 21 (10): 1448–1457. doi:10.1016/S1473-3099(20)30687-3. PMID 34043963. S2CID 235230838.
Castle PE, Scarinci I (October 2009). "Should HPV vaccine be given to men?". BMJ. 339 (7726): b4127. doi:10.1136/bmj.b4127. PMID 19815585. S2CID 1922594.
Muñoz N, Bosch FX, Castellsagué X, Díaz M, de Sanjose S, Hammouda D, et al. (August 2004). "Against which human papillomavirus types shall we vaccinate and screen? The international perspective". International Journal of Cancer. 111 (2): 278–285. doi:10.1002/ijc.20244. PMID 15197783. S2CID 20679802.
Thompson EL, Livingston MD, Daley EM, Saslow D, Zimet GD (August 2020). "Rhode Island Human Papillomavirus Vaccine School Entry Requirement Using Provider-Verified Report". American Journal of Preventive Medicine. 59 (2): 274–277. doi:10.1016/j.amepre.2020.02.022. hdl:1805/28509. PMID 32430223. S2CID 218758834.
Toh ZQ, Russell FM, Garland SM, Mulholland EK, Patton G, Licciardi PV (April 2021). "Human Papillomavirus Vaccination After COVID-19". JNCI Cancer Spectrum. 5 (2). Oxford University Press: pkab011. doi:10.1093/jncics/pkab011. eISSN 2515-5091. PMC 7962726. PMID 33748668. S2CID 232295180.
Daniels V, Saxena K, Roberts C, Kothari S, Corman S, Yao L, Niccolai L (May 2021). Poland G (ed.). "Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis". Vaccine. 39 (20). Elsevier: 2731–2735. doi:10.1016/j.vaccine.2021.04.003. PMC 8023201. PMID 33875269. S2CID 233034581.
"Boys aged 12 and 13 years to be offered HPV vaccine from September 2019, PHE announces". Pharmaceutical Journal. 303 (7927). July 2019. doi:10.1211/PJ.2019.20206777. ISSN 2053-6186. S2CID 239219776. Archived from the original on 9 August 2022.
Gilmour S, Kanda M, Kusumi E, Tanimoto T, Kami M, Shibuya K (August 2013). "HPV vaccination programme in Japan". Lancet. 382 (9894): 768. doi:10.1016/S0140-6736(13)61831-0. PMID 23993189. S2CID 40619281.
Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, et al. (June 2021). "Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework" (PDF). Vaccine. 39 (27): 3565–3581. doi:10.1016/j.vaccine.2021.05.013. PMID 34034949. S2CID 235203871. Archived (PDF) from the original on 19 June 2022. Retrieved 8 June 2022.
Moghtaderi A, Adams S (June 2016). "The Role of Physician Recommendations and Public Policy in Human Papillomavirus Vaccinations". Applied Health Economics and Health Policy. 14 (3): 349–359. doi:10.1007/s40258-016-0225-6. PMID 26873090. S2CID 25655517.
Reno JE, Dempsey AF (February 2022). "Promoting HPV vaccination among Latinx: an application of the extended parallel processing model". Journal of Behavioral Medicine. 46 (1–2): 324–334. doi:10.1007/s10865-022-00293-7. PMID 35178652. S2CID 246905792.
Gostin LO (June 2018). "HPV Vaccination: A Public Good and a Health Imperative". The Journal of Law, Medicine & Ethics. 46 (2): 511–513. doi:10.1177/1073110518782958. PMID 30147001. S2CID 52092917.
Malmqvist E, Helgesson G, Lehtinen J, Natunen K, Lehtinen M (February 2011). "The ethics of implementing human papillomavirus vaccination in developed countries". Medicine, Health Care and Philosophy. 14 (1): 19–27. doi:10.1007/s11019-010-9285-9. PMID 20853152. S2CID 27444545.
Albarran Y, Carvajal A, de la Garza A, Cruz Quiroz BJ, Vazquez Zea E, Díaz Estrada I, et al. (2007). "MVA E2 recombinant vaccine in the treatment of human papillomavirus infection in men presenting intraurethral flat condyloma: a phase I/II study". BioDrugs. 21 (1): 47–59. doi:10.2165/00063030-200721010-00006. PMID 17263589. S2CID 26415621.

service-public.fr

"Cancer of the cervix: reimbursement of Gardasil" (in French). 17 July 2007. Archived from the original on 18 December 2014. Retrieved 10 August 2013.

ssi.dk

en.ssi.dk

"Childhood vaccination programme". en.ssi.dk. National Institute for Health Data and Disease Control. Archived from the original on 28 November 2019. Retrieved 28 November 2019.

standard.co.uk

Herbert T (2 September 2019). "What is the HPV vaccine for boys and are there any side effects?". Evening Standard. Archived from the original on 7 November 2020. Retrieved 6 January 2021.

startribune.com

Stobbe M (19 June 2013). "Study: Vaccine against sexually transmitted HPV cut infections in teen girls by half". Star Tribune. Archived from the original on 23 June 2013. Retrieved 7 August 2013.

statements.qld.gov.au

Bligh A (10 June 2009). "Premier Unveils Queensland's 150 Icons" (Press release). Queensland Government. Archived from the original on 24 May 2017. Retrieved 24 May 2017.

stjude.org

Sheffield M, Hobgood K (30 August 2021). "St. Jude and leading cancer centers urge vaccination to protect against HPV and other diseases". www.stjude.org. Memphis, Tennessee: St. Jude Children's Research Hospital. Archived from the original on 15 November 2021. Retrieved 8 September 2021.

stm.fi

"HPV vaccination: Coverage". Ministry of Social Affairs and Health. 18 February 2010. Archived from the original on 26 April 2017. Retrieved 25 April 2017.

sussex.ac.uk

sro.sussex.ac.uk

Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, et al. (June 2021). "Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework" (PDF). Vaccine. 39 (27): 3565–3581. doi:10.1016/j.vaccine.2021.05.013. PMID 34034949. S2CID 235203871. Archived (PDF) from the original on 19 June 2022. Retrieved 8 June 2022.

tga.gov.au

"Gardasil (human papillomavirus vaccine)". Therapeutic Goods Administration (TGA). 24 June 2010. Archived from the original on 23 March 2022. Retrieved 8 July 2022.
"AusPAR: Human papillomavirus quadrivalent vaccine". Therapeutic Goods Administration (TGA). 24 February 2011. Archived from the original on 18 June 2022. Retrieved 8 July 2022.
"AusPAR: Human Papillomavirus 9 valent vaccine". Therapeutic Goods Administration (TGA). 16 January 2017. Archived from the original on 4 April 2019. Retrieved 8 July 2022.
"AusPAR: Human papillomavirus (Types 6, 11, 16 & 18) quadrivalent recombinant vaccine". Therapeutic Goods Administration (TGA). 7 June 2012. Archived from the original on 9 September 2017. Retrieved 8 July 2022.

search.tga.gov.au

"Gardasil HPV 6 L1 Protein / HPV 11 L1 Protein / HPV 16 L1 Protein / HPV 18 L1 Protein 20,40,40,20 micrograms/0.5mL sterile liquid syringe". Therapeutic Goods Administration (TGA). Archived from the original on 8 July 2022. Retrieved 8 July 2022.
"Gardasil 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe". Therapeutic Goods Administration (TGA). Archived from the original on 8 July 2022. Retrieved 8 July 2022.
"Gardasil 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms / 0.5mL, suspension for injection, vial". Therapeutic Goods Administration (TGA). Archived from the original on 8 July 2022. Retrieved 8 July 2022.

thejournal.ie

Ní Aodha G (11 August 2019). "Explainer: The HPV vaccine is free for boys from next month - here's why that's important". thejournal.ie. Archived from the original on 5 January 2021. Retrieved 6 January 2021.

thenational.ae

Al Nowais S (21 May 2016). "Greater understanding of HPV in UAE may help reduce cervical cancer cases". The National. Archived from the original on 17 September 2018. Retrieved 17 September 2018.
Al Hassani Z (14 May 2013). "Free vaccination against cervical cancer for Abu Dhabi women". The National. Archived from the original on 17 September 2018. Retrieved 17 September 2018.

ticotimes.net

"Costa Rica to begin administering HPV vaccine". The Tico Times Costa Rica. 25 April 2019. Archived from the original on 15 June 2019. Retrieved 14 June 2019.
"Costa Rica begins nationwide HPV vaccination campaign". The Tico Times Costa Rica. 4 June 2019. Archived from the original on 12 June 2019. Retrieved 14 June 2019.

unsw.edu.au

kirby.unsw.edu.au

"2011 Annual Surveillance Report of HIV, viral hepatitis, STIs". The Kirby Institute for Infection and Immunity. Sydney NSW: University of New South Wales. p. 28. Archived from the original on 22 May 2013.

usatoday.com

usatoday30.usatoday.com

"1 in 4 US teen girls got cervical cancer shot". USA Today. Associated Press. 9 October 2008. Archived from the original on 14 October 2013. Retrieved 10 August 2013.

uspreventiveservicestaskforce.org

"Cervical Cancer: Screening". United States Preventive Services Task Force (USPSTF). August 2018. Archived from the original on 7 November 2018. Retrieved 7 November 2018.

vaccinerx.com

Fagbire OJ (26 March 2007). "Gardasil, Merck HPV Vaccine, Gets German And Italian Approval For Girls". Vaccine Rx. Archived from the original on 28 September 2007. Retrieved 10 August 2013.

vanguardia.com

Carvajal Pineda L (4 September 2012). "Girón ya está vacunando contra el papiloma humano". Vanguardia (in Spanish). Archived from the original on 4 March 2016. Retrieved 29 July 2015.

washingtonpost.com

Sprigg P (15 July 2006). "Pro-Family, Pro-Vaccine—But Keep It Voluntary". The Washington Post. Archived from the original on 5 November 2012. Retrieved 4 February 2007.

web.archive.org

"Human papillomavirus vaccine Use During Pregnancy". Drugs.com. 11 February 2019. Archived from the original on 5 April 2020. Retrieved 3 April 2020.
"Gardasil HPV 6 L1 Protein / HPV 11 L1 Protein / HPV 16 L1 Protein / HPV 18 L1 Protein 20,40,40,20 micrograms/0.5mL sterile liquid syringe". Therapeutic Goods Administration (TGA). Archived from the original on 8 July 2022. Retrieved 8 July 2022.
"Gardasil 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe". Therapeutic Goods Administration (TGA). Archived from the original on 8 July 2022. Retrieved 8 July 2022.
"Gardasil 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms / 0.5mL, suspension for injection, vial". Therapeutic Goods Administration (TGA). Archived from the original on 8 July 2022. Retrieved 8 July 2022.
"Gardasil (human papillomavirus vaccine)". Therapeutic Goods Administration (TGA). 24 June 2010. Archived from the original on 23 March 2022. Retrieved 8 July 2022.
"AusPAR: Human papillomavirus quadrivalent vaccine". Therapeutic Goods Administration (TGA). 24 February 2011. Archived from the original on 18 June 2022. Retrieved 8 July 2022.
"AusPAR: Human Papillomavirus 9 valent vaccine". Therapeutic Goods Administration (TGA). 16 January 2017. Archived from the original on 4 April 2019. Retrieved 8 July 2022.
"AusPAR: Human papillomavirus (Types 6, 11, 16 & 18) quadrivalent recombinant vaccine". Therapeutic Goods Administration (TGA). 7 June 2012. Archived from the original on 9 September 2017. Retrieved 8 July 2022.
"Gardasil Product information". Health Canada. 25 April 2012. Archived from the original on 8 July 2022. Retrieved 8 July 2022.
"Gardasil 9 Product information". Health Canada. 25 April 2012. Archived from the original on 6 May 2021. Retrieved 8 July 2022.
"Gardasil 9 suspension for injection - Summary of Product Characteristics (SmPC)". (emc). 24 January 2020. Archived from the original on 6 April 2020. Retrieved 3 April 2020.
"Gardasil suspension for injection - Summary of Product Characteristics (SmPC)". (emc). 7 May 2019. Archived from the original on 4 April 2020. Retrieved 3 April 2020.
"Gardasil- human papillomavirus quadrivalent- types 6, 11, 16, and 18 vaccine, recombinant injection, suspension". DailyMed. 2 December 2020. Archived from the original on 21 April 2022. Retrieved 31 March 2022.
"Gardasil 9- human papillomavirus 9-valent vaccine, recombinant injection, suspension". DailyMed. 20 August 2021. Archived from the original on 5 April 2020. Retrieved 31 March 2022.
"Cervarix". U.S. Food and Drug Administration (FDA). 4 October 2022. STN:BL 125259. Archived from the original on 10 October 2022. Retrieved 9 October 2022.
"Silgard EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020.
"Gardasil 9 EPAR". European Medicines Agency (EMA). 17 September 2018. Archived from the original on 6 April 2020. Retrieved 3 April 2020. Text was copied from this source which is copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"Gardasil EPAR". European Medicines Agency. 17 September 2018. Archived from the original on 11 June 2022. Retrieved 6 July 2022.
Anjum F, Zohaib J (4 December 2020). "Oropharyngeal Squamous Cell Carcinoma". StatPearls (Updated ed.). Treasure Island (FL): StatPearls Publishing. doi:10.32388/G6TG1L. PMID 33085415. S2CID 229252540. Bookshelf ID: NBK563268. Archived from the original on 11 June 2021. Retrieved 7 February 2021 – via NCBI.
"What's New with VISs". Centers for Disease Control and Prevention (CDC). 5 April 2019. Archived from the original on 15 October 2019. Retrieved 14 October 2019.
"The HPV Vaccine: Access and Use in the U.S." The Henry J. Kaiser Family Foundation. 12 July 2021. Archived from the original on 31 December 2022. Retrieved 1 January 2023.
"FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old". U.S. Food and Drug Administration (FDA) (Press release). 5 October 2018. Archived from the original on 14 October 2019. Retrieved 14 October 2018.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (August 2019). "Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices" (PDF). MMWR. Morbidity and Mortality Weekly Report. 68 (32): 698–702. doi:10.15585/mmwr.mm6832a3. PMC 6818701. PMID 31415491. Archived (PDF) from the original on 13 October 2019. Retrieved 15 October 2019.
"Human Papillomavirus (HPV) Vaccines: Q & A". Fact Sheets: Risk Factors and Possible Causes. National Cancer Institute (NCI). 22 October 2009. Archived from the original on 21 June 2008. Retrieved 18 July 2008.
"Cervical Cancer: Screening". United States Preventive Services Task Force (USPSTF). August 2018. Archived from the original on 7 November 2018. Retrieved 7 November 2018.
Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER (March 2007). "Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Recommendations and Reports. 56 (RR-2): 1–24. PMID 17380109. Archived (PDF) from the original on 24 September 2015.
"HPV Vaccines". Centers for Disease Control and Prevention (CDC). 15 October 2010. Archived from the original on 4 October 2015. Retrieved 27 February 2011.
"Meeting of the Advisory Committee on Immunization Practices (ACIP)" (PDF). Centers for Disease Control and Prevention (CDC). 14 October 2016. Archived (PDF) from the original on 21 October 2016. Retrieved 21 October 2016.
"FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old". U.S. Food and Drug Administration. Archived from the original on 14 October 2019. Retrieved 9 November 2019.
"Human Papillomavirus (HPV) Prevention and HPV Vaccines: Questions and Answers". Public Health Agency of Canada. 18 June 2007. Archived from the original on 26 September 2019. Retrieved 9 November 2019.
"FDA Approves New Indication for Gardasil to Prevent Genital Warts in Men and Boys" (Press release). U.S. Food and Drug Administration (FDA). Archived from the original on 24 October 2009. Retrieved 30 October 2009.
Centers for Disease Control and Prevention (CDC) (May 2010). "FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)" (PDF). MMWR. Morbidity and Mortality Weekly Report. 59 (20): 630–632. PMID 20508594. Archived (PDF) from the original on 24 September 2015.
"Vaccine Information Statement". Centers for Disease Control and Prevention (CDC). Archived from the original on 21 November 2015. Retrieved 20 November 2015.
Rosenthal E (19 August 2008). "Drug Makers' Push Leads to Cancer Vaccines' Fast Rise". The New York Times. Archived from the original on 9 April 2009. Retrieved 20 August 2008. Said Dr. Raffle, the British cervical cancer specialist: 'Oh, dear. If we give it to boys, then all pretense of scientific worth and cost analysis goes out the window.'
"Gay men seeking HPV vaccine". Cancer Research UK. 23 February 2007. Archived from the original on 24 March 2010. Retrieved 30 October 2009.
Karen Canfell: The road to cervical cancer elimination, archived from the original on 17 December 2021, retrieved 14 April 2022
Ní Aodha G (11 August 2019). "Explainer: The HPV vaccine is free for boys from next month - here's why that's important". thejournal.ie. Archived from the original on 5 January 2021. Retrieved 6 January 2021.
Herbert T (2 September 2019). "What is the HPV vaccine for boys and are there any side effects?". Evening Standard. Archived from the original on 7 November 2020. Retrieved 6 January 2021.
"Vacinas: Meningite B e HPV para rapazes passam a ser gratuitas em 2020 - DN". www.dn.pt (in Portuguese). 27 December 2019. Archived from the original on 30 January 2020. Retrieved 30 January 2020.
"FDA: Gardasil approved to prevent anal cancer" (Press release). U.S. Food and Drug Administration (FDA). 2010. Archived from the original on 18 December 2014. Retrieved 15 January 2015.
"Gardasil". U.S. Food and Drug Administration (FDA). 25 April 2019. STN 125126. Archived from the original on 15 October 2019. Retrieved 15 October 2019.
"Gardasil 9". U.S. Food and Drug Administration (FDA). 25 April 2019. STN 125508. Archived from the original on 15 October 2019. Retrieved 15 October 2019.
Rettner R (25 October 2011). "Boys Should Get HPV Vaccine Too, CDC Says". LiveScience. Archived from the original on 3 July 2012. Retrieved 11 November 2011.
Montague L (5 October 2018). "Summary Basis for Regulatory Action" (PDF). U.S. Food and Drug Administration (FDA). Archived from the original on 14 December 2019. Retrieved 7 August 2019.
"ESGO Statement on Cervical Cancer Vaccination" (PDF). ESGO. 2007. Archived from the original (PDF) on 26 July 2011.
"Cervarix Marketing in Kenya". Medical News Today. Archived from the original on 3 January 2009. Retrieved 17 September 2010.
Attkisson S (19 August 2009). "Gardasil Researcher Speaks Out". CBS News. Archived from the original on 3 March 2022. Retrieved 3 March 2022.
Yerman MG (28 December 2009). "An Interview with Dr. Diane M. Harper, HPV Expert". Huffington Post. Archived from the original on 13 August 2013. Retrieved 28 August 2013.
Haelle T (23 February 2016). "HPV Infection Rates Plummet In Young Women Due To Vaccine". Forbes. Archived from the original on 26 February 2016. Retrieved 23 February 2016.
"Human papillomavirus (HPV) vaccines for Australians" (PDF). National Centre for Immunisation Research and Surveillance Factsheet. March 2013. Archived from the original (PDF) on 20 April 2013.
"GARDASIL®, Merck's HPV Vaccine, Available to Developing Countries through UNICEF Tender". BusinessWire. 9 May 2013. Archived from the original on 18 December 2014. Retrieved 8 September 2013.
"Reports of Health Concerns Following HPV Vaccination". Centers for Disease Control and Prevention (CDC). 5 November 2009. Archived from the original on 17 September 2013. Retrieved 8 September 2013.
"Review concludes evidence does not support that HPV vaccines cause CRPS or POTS" (PDF) (Press release). European Medicines Agency (EMA). 5 November 2015. Archived (PDF) from the original on 14 February 2016. Retrieved 5 November 2015.
"Information from FDA and CDC on Gardasil and its Safety". Centers for Disease Control and Prevention (CDC). 22 July 2008. Archived from the original on 2 September 2013. Retrieved 8 September 2013.
"Human Papillomavirus (HPV) Vaccines". 25 May 2018. Archived from the original on 4 July 2014.
"HPV Vaccine Information for Clinicians – Fact Sheet". CDC. 11 January 2019. Archived from the original on 1 May 2012.
"Human Papillomavirus (HPV) Vaccine Recommendations" (PDF). FDA. Archived from the original (PDF) on 7 March 2014.
"Gardasil Pregnancy Registry". Merck & Co. 1 February 2012. Archived from the original on 1 March 2012. Retrieved 29 May 2007.
"Gardasil 9 Pregnancy Registry". Merck & Co. Archived from the original on 28 August 2018. Retrieved 21 October 2019.
"Who Should NOT Get Vaccinated with these Vaccines?". Centers for Disease Control and Prevention (CDC). 10 June 2010. Archived from the original on 11 May 2011. Retrieved 27 February 2011.
"HPV Vaccine and Pregnancy". eMedTV. Archived from the original on 24 July 2012.
"leftside". Ciitn.missouri.edu. 22 January 2007. Archived from the original on 2 October 2013. Retrieved 29 December 2013.
"FDA Licenses New Vaccine for Prevention of Cervical Cancer and Other Diseases in Females Caused by Human Papillomavirus" (Press release). U.S. Food and Drug Administration (FDA). 8 June 2006. Archived from the original on 19 October 2009. Retrieved 13 November 2009.
"Merck Reports Double-Digit Earnings-Per-Share Growth for Second Quarter 2007" (Press release). Archived from the original on 12 October 2007. Retrieved 16 October 2019.
"Glaxo prepares to launch Cervarix after EU okay". Reuters. 24 September 2007. Archived from the original on 25 October 2008. Retrieved 18 July 2008.
"16 October 2009 Approval Letter – Cervarix". U.S. Food and Drug Administration (FDA). 16 October 2009. Archived from the original on 19 October 2009. Retrieved 13 November 2009.
"The Genital HPV Infection Fact Sheet". Centers for Disease Control and Prevention (CDC). 24 November 2009. Archived from the original on 28 June 2013. Retrieved 13 February 2010.
"FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV" (press release). U.S. Food and Drug Administration (FDA). 10 December 2014. Archived from the original on 10 January 2015. Retrieved 9 January 2015.
McNeil Jr DG (5 May 2013). "Cancer Vaccines Get a Price Cut in Poor Nations". The New York Times. Archived from the original on 23 November 2013. Retrieved 23 November 2013.
Sheffield M, Hobgood K (30 August 2021). "St. Jude and leading cancer centers urge vaccination to protect against HPV and other diseases". www.stjude.org. Memphis, Tennessee: St. Jude Children's Research Hospital. Archived from the original on 15 November 2021. Retrieved 8 September 2021.
Highleyman L (3 September 2021). "Get HPV Vaccination Back on Track, Experts Urge". POZ. New York City. ISSN 1075-5705. Archived from the original on 8 September 2021. Retrieved 8 September 2021.
Frazer I. "Human papillomavirus vaccine – New and underused vaccines support – Types of support". GAVI Alliance. Archived from the original on 18 January 2014. Retrieved 29 December 2013.
"Information about the HPV immunisation program". The Immunise Australia Program. Department of Health, Commonwealth of Australia. Archived from the original on 4 May 2015.
"Historical Human Papillomavirus (HPV) immunisation coverage rates". Australian Government Department of Health. 4 December 2019. Archived from the original on 28 September 2021. Retrieved 28 September 2021.
"2011 Annual Surveillance Report of HIV, viral hepatitis, STIs". The Kirby Institute for Infection and Immunity. Sydney NSW: University of New South Wales. p. 28. Archived from the original on 22 May 2013.
"Pharmaceutical Benefits Scheme (PBS) | Recommendations made by the PBAC - November 2011". Australian Government Department of Health. Archived from the original on 19 April 2013.
"Young men to be protected from cancers through HPV vaccine". Australian Cancer Research Foundation. 13 July 2012. Archived from the original on 28 September 2021. Retrieved 28 September 2021.
"Summary Safety Review - Gardasil (Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) - Assessing General Safety with a Focus on Autoimmune and Cardiovascular Diseases". Health Canada. 9 December 2015. Archived from the original on 26 September 2019. Retrieved 21 October 2019.
Dawar DM, Harris MT, McNeil DS (January 2012). "Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) ^†". Canada Communicable Disease Report. 38 (ACS-1): 1–62. doi:10.14745/ccdr.v38i00a01. PMC 6802461. PMID 31701955. Archived from the original on 21 October 2019. Retrieved 21 October 2019.
"GSK announces Cervarix approved in China to help protect women from cervical cancer". GlaxoSmithKline (Press release). 18 July 2016. Archived from the original on 24 July 2016. Retrieved 20 October 2019.
"Cervarix is approved for cervical cancer prevention in female population aged 9-45 years in mainland China". GlaxoSmithKline (Press release). 29 May 2018. Archived from the original on 31 March 2019. Retrieved 20 October 2019.
"Cervarix, first vaccine for cervical cancer prevention in mainland China, has officially launched". GlaxoSmithKline (Press release). 31 July 2017. Archived from the original on 4 September 2017. Retrieved 20 October 2019.
Carvajal Pineda L (4 September 2012). "Girón ya está vacunando contra el papiloma humano". Vanguardia (in Spanish). Archived from the original on 4 March 2016. Retrieved 29 July 2015.
"ABC VPH vaccine". www.minsalud.gov.co. Archived from the original on 4 August 2015. Retrieved 29 July 2015.
"Costa Rica to begin administering HPV vaccine". The Tico Times Costa Rica. 25 April 2019. Archived from the original on 15 June 2019. Retrieved 14 June 2019.
"Costa Rica begins nationwide HPV vaccination campaign". The Tico Times Costa Rica. 4 June 2019. Archived from the original on 12 June 2019. Retrieved 14 June 2019.
"Impfkalender für Schulkinder". Archived from the original on 24 September 2016. Retrieved 6 September 2016.
"Childhood vaccination programme". en.ssi.dk. National Institute for Health Data and Disease Control. Archived from the original on 28 November 2019. Retrieved 28 November 2019.
"HPV vaccination: Coverage". Ministry of Social Affairs and Health. 18 February 2010. Archived from the original on 26 April 2017. Retrieved 25 April 2017.
"HPV vaccine will now also be offered to boys". Lääketietokeskus. 20 May 2020. Archived from the original on 9 August 2020. Retrieved 3 September 2020.
"Cancer of the cervix: reimbursement of Gardasil" (in French). 17 July 2007. Archived from the original on 18 December 2014. Retrieved 10 August 2013.
Fagbire OJ (26 March 2007). "Gardasil, Merck HPV Vaccine, Gets German And Italian Approval For Girls". Vaccine Rx. Archived from the original on 28 September 2007. Retrieved 10 August 2013.
"HPV-Impfung jetzt auch für Jungen Kassenleistung" (in German). Kassenärztliche Vereinigung. 6 December 2018. Archived from the original on 1 December 2020. Retrieved 18 November 2020.
Karakitsos P (7 March 2008). "Vaccination against HPV in Greece" (in Greek). Archived from the original on 30 April 2013. Retrieved 10 August 2013.
"The vaccine against cervical cancer and Cervarix vs Gardasil" (in Greek). 12 February 2008. Archived from the original on 13 June 2013. Retrieved 10 August 2013.
"Méhnyakrák megelőzése, HPV". www.antsz.hu. Archived from the original on 3 September 2014. Retrieved 16 October 2019.
Cullen P. "HPV vaccine to be offered to boys from start of school year in 2019". The Irish Times. Archived from the original on 4 September 2019. Retrieved 16 October 2019.
"Vaccination programmes". Folkhälsomyndigheten. The Public Health Agency of Sweden. 18 February 2022. Archived from the original on 12 July 2022. Retrieved 26 November 2022.
"Statistik för HPV-vaccinationer — Folkhälsomyndigheten". Folkhälsomyndigheten (in Swedish). 14 May 2022. Archived from the original on 2 June 2022. Retrieved 26 November 2022.
"Vaccin mot humant papillomvirus (HPV) — Folkhälsomyndigheten". Folkhälsomyndigheten (in Swedish). 21 February 2022. Archived from the original on 26 October 2022. Retrieved 26 November 2022.
"Boys aged 12 and 13 years to be offered HPV vaccine from September 2019, PHE announces". Pharmaceutical Journal. 303 (7927). July 2019. doi:10.1211/PJ.2019.20206777. ISSN 2053-6186. S2CID 239219776. Archived from the original on 9 August 2022.
"HPV vaccine overview". nhs.uk. 31 July 2019. Archived from the original on 1 January 2019. Retrieved 5 February 2022.
"Centre for Health Protection, Department of Health - About human papillomavirus (HPV) vaccination". www.chp.gov.hk. Archived from the original on 8 March 2021. Retrieved 15 August 2020.
"HSPC HPV vaccine uptake in Ireland" (PDF). Archived from the original (PDF) on 11 January 2019. Retrieved 16 October 2019.
"HSE Guidelines for staff HPV second level school vaccination campaign" (PDF). Archived (PDF) from the original on 11 January 2019. Retrieved 16 October 2019.
"HPV". HSE.ie. Archived from the original on 12 January 2019. Retrieved 11 January 2019.
"Irish times- HPV vaccine to be offered to boys from start of school year in 2019". The Irish Times. Archived from the original on 8 December 2018. Retrieved 11 January 2019.
"health.gov.il". Ministry of Health. Israel. Archived from the original on 29 October 2013.
Siegel J (9 October 2013). "Health Ministry decides to offer free HPV vaccine to 13-year-old girls | JPost | Israel News". JPost. Archived from the original on 2 December 2013. Retrieved 29 December 2013.
Mulcahy N (25 June 2013). "Japan Withdraws HPV Vaccine Recommendation for Girls". Medscape. Archived from the original on 23 April 2020. Retrieved 17 May 2020.
"Japan to Resume Active Promotion of HPV Vaccinations in April". Jiji Press News. 26 November 2021. Archived from the original on 28 November 2021. Retrieved 28 November 2021.
"'Finally we can protect women': Japan's HPV vaccine battle". AFP News. 31 March 2022. Archived from the original on 22 April 2022. Retrieved 2 April 2022.
"Japan to allow free HPV vaccines to women born FY1997-2005 after 8-year hiatus". Mainichi Shimbun. 24 December 2021. Archived from the original on 28 December 2021. Retrieved 28 December 2021.
"Japan to Give Free HPV Vaccinations to Those Who Missed Them". nippon.com. 15 November 2021. Archived from the original on 15 November 2021. Retrieved 4 February 2022.
"New technologies for cervical cancer prevention: from scientific evidence to program planning". Pan American Health Organization. Archived from the original on 9 May 2012. Retrieved 18 April 2012.
"Progress Toward Implementation of Human Papillomavirus Vaccination—the Americas, 2006–2010". Center for Disease and Control Prevention. Archived from the original on 9 May 2012. Retrieved 18 April 2012.
"Questions and answers about HPV immunisation". Ministry of Health NZ. 29 September 2021. Archived from the original on 26 February 2018. Retrieved 24 November 2021.
Green A (7 June 2013). "Life saving cancer vaccine will be difficult to implement". Mail & Guardian. Archived from the original on 17 July 2013. Retrieved 7 August 2013.
SAPA (15 May 2013). "Schoolgirls to get cancer vaccine". ioL News. Archived from the original on 12 August 2013. Retrieved 7 August 2013.
"가다실 제품 허가 공지". 27 June 2007. Archived from the original on 29 September 2007. Retrieved 6 August 2007.
"[기획] 어린이 자궁경부암 예방접종 무료…가다실 Vs 서바릭스 어떤 백신 도입될까". 18 January 2016. Archived from the original on 3 February 2016. Retrieved 27 January 2016.
"[자궁경부'앎'은 힘이다! - 가다실] "자궁경부암 백신 무료접종으로 공중보건 질적 향상 기대" - 라포르시안". rapportian.com. 5 April 2016. Archived from the original on 28 August 2021. Retrieved 7 May 2018.
"HPV vaccine for first form students in Barbados while Trinidad suspends the same in schools". Caribbean Medical News. 1 December 2013. Archived from the original on 27 October 2021. Retrieved 27 October 2021.
D'Souza C (24 April 2013). "Cervical cancer vaccination could be mandatory in UAE". Gulf News. Archived from the original on 16 September 2018. Retrieved 16 September 2018.
Al Nowais S (21 May 2016). "Greater understanding of HPV in UAE may help reduce cervical cancer cases". The National. Archived from the original on 17 September 2018. Retrieved 17 September 2018.
"UAE gets cervical cancer vaccine". Khaleej Times. 7 January 2007. Archived from the original on 17 September 2018. Retrieved 17 September 2018.
"Prevention". Archived from the original on 16 September 2018. Retrieved 16 September 2018.
Al Hassani Z (14 May 2013). "Free vaccination against cervical cancer for Abu Dhabi women". The National. Archived from the original on 17 September 2018. Retrieved 17 September 2018.
Al-Sabai W (15 September 2018). "قرار وزاري بإلزامية تطعيم سرطان عنق الرحم" [A ministerial decision mandating cervical cancer vaccination]. Emarat Alyoum (in Arabic). Archived from the original on 15 September 2018. Retrieved 16 September 2018.
Al Ali I (15 September 2018). "Cervical cancer vaccination for Dubai schools". Gulf Today. Archived from the original on 15 September 2018. Retrieved 16 September 2018.
Roberts M (23 February 2007). "Gay men seek 'female cancer' jab". BBC. Archived from the original on 30 January 2009.
"NHS Cervical Screening Program". Archived from the original on 14 September 2008. Retrieved 26 June 2008.
"HPV vaccine". nhs.uk. 9 May 2018. Archived from the original on 1 January 2019. Retrieved 3 January 2019.
Nadarzynski T, Frost M, Miller D, Wheldon CW, Wiernik BM, Zou H, et al. (June 2021). "Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework" (PDF). Vaccine. 39 (27): 3565–3581. doi:10.1016/j.vaccine.2021.05.013. PMID 34034949. S2CID 235203871. Archived (PDF) from the original on 19 June 2022. Retrieved 8 June 2022.
"JCVI statement: extending the HPV vaccination programme – conclusions". GOV.UK. Archived from the original on 4 January 2019. Retrieved 4 January 2019.
"Boots launches HPV vaccination for boys and men". The Pharmaceutical Journal. 298 (7900). April 2017. doi:10.1211/PJ.2017.20202616. ISSN 2053-6186. Archived from the original on 4 July 2022.
"Human papillomavirus (HPV): the green book, chapter 18a". Public Health England. 20 March 2013. Archived from the original on 15 October 2019. Retrieved 3 January 2019.
"1 in 4 US teen girls got cervical cancer shot". USA Today. Associated Press. 9 October 2008. Archived from the original on 14 October 2013. Retrieved 10 August 2013.
"More US Girls Now Getting Cervical Cancer Vaccine". Discovery and Development. Associated Press. 25 July 2014. Archived from the original on 26 July 2014.
"HPV Vaccine Information For Young Women". Centers for Disease Control and Prevention (CDC). Archived from the original on 28 June 2009. Retrieved 14 June 2009.
Caskey R, Lindau ST, Alexander GC (November 2009). "Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey". The Journal of Adolescent Health. 45 (5): 453–462. doi:10.1016/j.jadohealth.2009.04.021. PMID 19837351. Archived from the original on 17 October 2014.
Stobbe M (19 June 2013). "Study: Vaccine against sexually transmitted HPV cut infections in teen girls by half". Star Tribune. Archived from the original on 23 June 2013. Retrieved 7 August 2013.
Knox R (19 June 2013). "Vaccine Against HPV Has Cut Infections In Teenage Girls". NPR. Archived from the original on 20 June 2013. Retrieved 21 June 2013.
"Immunization Information for Schools & Childcare Providers: Department of Health". www.health.ri.gov. Archived from the original on 21 November 2015. Retrieved 20 November 2015.
Jordan M (1 October 2008). "Gardasil Requirement for Immigrants Stirs Backlash". The Wall Street Journal. Archived from the original on 18 December 2014. Retrieved 15 January 2009.
"Green card seekers won't have to get HPV vaccine". 16 November 2009. Archived from the original on 27 September 2011. Retrieved 31 January 2011.
"Vaccines for Children Program (VFC)". Centers for Disease Control and Prevention. Archived from the original on 28 September 2013. Retrieved 10 August 2013.
"ACA Preventative Services Benefits for Women and Pregnant Women". Immunization for Women. Archived from the original on 9 September 2013. Retrieved 10 August 2013.
"Human Papillomavirus Vaccination Coverage Among Female Adolescents in Managed Care Plans — United States, 2013". Center of Disease Control and Prevention. 30 October 2015. Archived from the original on 18 October 2020. Retrieved 10 September 2020.
"About VFC". Centers for Disease Control and Prevention (CDC). 25 May 2018. Archived from the original on 7 November 2018. Retrieved 7 November 2018.
"Patient Eligibility". GSK Vaccine Access Program. GlaxoSmithKline. Archived from the original on 9 April 2016.
"Patient Assistance for Vaccines | GSKForYou". www.gskforyou.com. Archived from the original on 15 July 2016. Retrieved 16 October 2019.
"GSK Vaccines Access Program". Archived from the original on 21 August 2016. Retrieved 16 October 2019.
"Merck Programs to Help Those in Need - Programs". www.merckhelps.com. Archived from the original on 5 June 2016. Retrieved 16 October 2019.
Fayed L (2007). "HPV Vaccine—Why Your Doctor Doesn't Offer the HPV Vaccine—Gardasil". About.com: Cancer. Archived from the original on 31 December 2007.
"Detroit News Examines Cost of HPV Vaccine Gardasil". Kaiser Family Foundation. 29 March 2007. Archived from the original on 15 October 2007.
"A question of protection". Archived from the original on 15 October 2007. Retrieved 16 October 2019.
Gabriel T, Grady D (13 September 2011). "Rick Perry Under Fire by Republican Rivals for Requiring HPV Vaccine for Girls". The New York Times. Archived from the original on 14 September 2011. Retrieved 22 February 2017.
Sprigg P (15 July 2006). "Pro-Family, Pro-Vaccine—But Keep It Voluntary". The Washington Post. Archived from the original on 5 November 2012. Retrieved 4 February 2007.
Coyne B (2 November 2005). "Cervical Cancer Vaccine Raises 'Promiscuity' Controversy". The New Standard. Archived from the original on 7 August 2006. Retrieved 28 August 2006.
"IF07B01". Family Research Council. 7 February 2008. Archived from the original on 4 August 2007.
"Position Statement: Human Papillomavirus Vaccines". Focus on the Family. Archived from the original on 30 August 2008. Retrieved 4 January 2008.
"Opposition To HPV Vaccine Stirs Passion, Bewilderment". ripr.org. 17 September 2015. Archived from the original on 21 November 2015. Retrieved 20 November 2015.
"HPV Vaccination Does Not Lead to Increased Sexual Activity" (press release). AAP. Archived from the original on 25 February 2014. Retrieved 3 February 2014.
"Lifesaving Politics". Ms. Spring 2007. pp. 12–13. Archived from the original on 1 June 2007.
Artega A. "The Shape and Structure of HPV". Zimbio. Archived from the original on 17 May 2013. Retrieved 7 March 2012.
"Virolab, Inc. – FORM 8-K/A". Getfilings.com. 24 June 2011. Archived from the original on 3 December 2013. Retrieved 29 December 2013.
"European Medicines Agency decision P/0367/2016" (PDF). www.ema.europa.eu. European Medicines Agency. Archived from the original (PDF) on 2 November 2017. Retrieved 2 November 2017.
"Inovio Begins Phase 3 Clinical Trial of VGX-3100 for the Treatment of HPV-Related Cervical Pre-Cancer". www.inovio.com. Inovio Pharmaceuticals. Archived from the original on 2 November 2017. Retrieved 2 November 2017.
"REVEAL 1 (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)". clinicaltrials.gov. The National Library of Medicine. Archived from the original on 2 November 2017. Retrieved 2 November 2017.
Bligh A (10 June 2009). "Premier Unveils Queensland's 150 Icons" (Press release). Queensland Government. Archived from the original on 24 May 2017. Retrieved 24 May 2017.
"NCI's Douglas R. Lowy and John T. Schiller to receive 2017 Lasker Award" (Press release). National Institutes of Health (NIH). 6 September 2017. Archived from the original on 7 November 2017.

who.int

"One-dose Human Papillomavirus (HPV) vaccine offers solid protection against cervical cancer". www.who.int.

wien.gv.at

"Impfkalender für Schulkinder". Archived from the original on 24 September 2016. Retrieved 6 September 2016.

worldcat.org

Toh ZQ, Russell FM, Garland SM, Mulholland EK, Patton G, Licciardi PV (April 2021). "Human Papillomavirus Vaccination After COVID-19". JNCI Cancer Spectrum. 5 (2). Oxford University Press: pkab011. doi:10.1093/jncics/pkab011. eISSN 2515-5091. PMC 7962726. PMID 33748668. S2CID 232295180.
Highleyman L (3 September 2021). "Get HPV Vaccination Back on Track, Experts Urge". POZ. New York City. ISSN 1075-5705. Archived from the original on 8 September 2021. Retrieved 8 September 2021.
"Boys aged 12 and 13 years to be offered HPV vaccine from September 2019, PHE announces". Pharmaceutical Journal. 303 (7927). July 2019. doi:10.1211/PJ.2019.20206777. ISSN 2053-6186. S2CID 239219776. Archived from the original on 9 August 2022.
"Boots launches HPV vaccination for boys and men". The Pharmaceutical Journal. 298 (7900). April 2017. doi:10.1211/PJ.2017.20202616. ISSN 2053-6186. Archived from the original on 4 July 2022.

wsj.com

Jordan M (1 October 2008). "Gardasil Requirement for Immigrants Stirs Backlash". The Wall Street Journal. Archived from the original on 18 December 2014. Retrieved 15 January 2009.

yahoo.com

sg.news.yahoo.com

"'Finally we can protect women': Japan's HPV vaccine battle". AFP News. 31 March 2022. Archived from the original on 22 April 2022. Retrieved 2 April 2022.

youtube.com

Karen Canfell: The road to cervical cancer elimination, archived from the original on 17 December 2021, retrieved 14 April 2022

zimbio.com

Artega A. "The Shape and Structure of HPV". Zimbio. Archived from the original on 17 May 2013. Retrieved 7 March 2012.